President's Report 2005 by Albany College of Pharmacy and Health Sciences

Presidentâ&#x20AC;&#x2122;s Report 2005

Contents Sciences for … life President’s message

Sciences for … innovation Coming into nano-focus

Sciences for … seeing The eyes have it Global vision

Sciences for … solving Questions of quality It all adds up

Sciences for … saving Like oil and water Of hearts and minds

Sciences for … discovery Research rocks! Career change Safety in numbers A jump start on research

Scholarly activity Pharmaceutical Research Institute Basic and Pharmaceutical Sciences Humanities and Social Sciences Pharmacy Practice

Board of Trustees Research Contact Information Financial Statements Gifts and donations Office of Institutional Advancement

27 27 28 30 37

Sciences for … life Why the fly? Why such a surprising image to lead off this edition of Albany College of Pharmacy’s President’s Report, the annual publication of research and scholarly activity at the institution? Because we understand that basic research is a vital component of an education in pharmacy and related health care fields. Drawing attention to and enhancing this critical fact is an important component of ACP’s strategic plan for curricular and programmatic development. Drosophila melanogaster – the fruit fly – is a model organism for genetic research. Its complex compound eye is a marvel of precisely organized structural elements that give great insight into genetic development. In our Department of Basic and Pharmaceutical Sciences, Assistant Professor Rich Dearborn, Ph.D., studies this development, looking for clues into cell communication (page 5). The translational benefits of Dr. Dearborn’s work are essential as the scientific community tries to better understand the development and treatment of diseases in humans. Dr. Dearborn’s research is equally important in the classroom, where students benefit from the opportunity to learn from a faculty member deployed on the cutting edge of genetic research. This information is fundamental to the education of pharmacists and

President’s message James J. Gozzo, Ph.D. health care professionals; the future of pharmaceutical care depends heavily on this understanding. A drug that works for you may not work for me. Why? Because we each have our own unique genetic structure, resulting in varied responses to medicines. Drug development and research around the world – and right here at ACP – is focused on expanding our knowledge of the human genome and developing medicines to target diseases and genes in a way that takes into consideration each individual’s unique genetic makeup. Faculty and students at ACP conduct novel research and scholarly activity in a broad spectrum of arenas. All under one theme – Sciences for Life. Seeking a better understanding of science to help provide longer, healthier lives. Connecting our knowledge of molecular structure with our knowledge of social structure to bet-

ter understand the patients our graduates serve. Throughout this publication you will have an opportunity to consider how seemingly disparate research interests merge to offer a more complete educational experience for students who will specialize in patient care. At ACP, we believe it is the confluence of all of these connections that prepare well-rounded pharmacists and health care professionals. You also will find within these pages the report of donors for 2005. I offer my thanks to all of you who have supported the institution. It would be impossible to achieve excellence in pharmacy, pharmaceutical sciences and biomedical technology without your generous contributions.

Sciences for … innovation

At the intersection of two of the most exciting new technologies in New York State’s Capital Region – nanotechnology and biotechnology – is a third cutting-edge development that promises scientific and medical breakthroughs that will save and improve lives while offering dramatic economic benefits. Nanopharmaceuticals. ACP is taking a leading role in this emerging field through the continued development of the Pharmaceutical Research Institute under the direction of Executive Vice President and Chairman Shaker Mousa. Led by Dr. Mousa (Ph.D., The Ohio State University), PRI realized the following growth in 2005: • Thanks to a $1 million grant through the State Senate and Assembly, the College renovated two floors of the 15,000-square-foot PRI building to

create the Preformulation and Stability Testing Laboratory. These stateof-the-art facilities have accelerated PRI’s use of nanotechnology and biotechnology to advance its work in drug discovery and development. • After receiving $3 million in equipment donations from the pharmaceutical industry in 2004, PRI received more than $5 million in capital assets in 2005. • PRI grew from three employees at the end of 2004 to 17 at the end of 2005, attracting specialists in nanotechnology, medicinal chemistry, molecular biology, cell biology and other related fields. PRI’s total employment is expected to double during 2006. A key element in PRI’s recruiting strategy is making connections with

other research institutes in the Capital Region and statewide. This is central to Dr. Mousa’s philosophy of multiplying the power of discovery through collaboration, both at ACP and beyond. “Building those bridges and having scientists working across the (research) institutes in New York State is the best way to build partnerships,” Dr. Mousa says. “It enhances everybody’s abilities.” One of PRI’s newest additions is Donald Armstrong, a specialist in ophthalmology who will work with the Japanese Ophthalmology Society to help bring Japanese postdoctoral fellows in ophthalmology to PRI. President and CEO of Oxidative Stress Associates Inc., Dr. Armstrong (Ed.D., University of Tulsa; Ph.D., University of Oslo School of Medicine; D.Sc., Charles University School of Medicine) holds faculty appointments at the Uni-

versity of Florida College of Medicine, the State University of New York at Buffalo and Showa University School of Medicine in Tokyo. Assistant Director of Biotechnology Ahmad Aljada joined PRI from Roswell Park Cancer Institute and the University at Buffalo. Dr. Aljada (Ph.D., University at Buffalo) is a biologist whose research has focused on the molecular mechanisms of insulin resistance in the obese and non-insulin-dependent diabetes, with particular emphasis on white blood cells and endothelial cells. He will foster existing collaboration among PRI, Roswell Park, the Ordway Research Institute and Albany Medical Center in those areas. Assistant Director of Pharmacology and Cell Biology David Lincoln has focused his research at the nearby Stratton VA Medical Center on hormonal modulation of breast cancer angiogenesis and metastasis. Dr. Lincoln (Ph.D., University of Pittsburgh) will carry out in vivo pharmacology studies at the VA. Joining PRI late in 2005 was Dhruba Jyoti Bharali, also from the University at Buffalo and Roswell Park. Dr. Bharali (Ph.D., University of Delhi) specializes in nanotechnology and its use in gene delivery, vaccine delivery, drug delivery, diagnosis and targeted delivery. As a member of both PRI and Roswell Park, he will strengthen the partnership between the two facilities. Chemist Srividya Revuru specializes in discovery and development of new synthetic methodologies and their application to synthesis of architecturally complex natural products or model compounds having pharmacological importance. A postdoctoral fellow at PRI and a visiting research scientist at the State University of New York at Albany, Dr. Revuru (Ph.D., Indian Institute of Chemical Technology) will enhance collaboration between PRI and the University at Albany.

Polymer chemist Haifeng Zhang has worked as a research consultant at GE Global Research and focuses on the synthesis and application of high-performance polymers, clay/polymer nanocomposites and functional polymers. Dr. Zhang (Ph.D., Rensselaer Polytechnic Institute) is a postdoctoral research fellow at PRI and will function

As PRI grows physically and in stature, so is its burgeoning role as a leader in nanopharmaceuticals – the use of drug-uptake particles 10,000 times smaller than the diameter of a human hair or 700 times smaller than the diameter of a human red blood cell. “Utilizing nanotechnology in formulation of existing and new medicines as

Coming into nano-focus Shaker A. Mousa, Ph.D.

as a bridge between the Institute and Rensselaer in the areas of heparin chemistry and pharmacokinetics. Dr. Mousa also remains busy with his own research, which focuses on angiogenesis, thrombosis and vascular disorders. Dr. Mousa filed, independently or in conjunction with other researchers in the Capital Region and beyond, six U.S. patent applications in late 2004 and 2005. Beside his previous publications, which exceed 600, he published 55 peerreviewed publications in 2005 and presented his work in various national and international conferences. He has been noted among the top 1 percent of cited authors for journals in the life sciences. Dr. Mousa also was recognized as one of the 10 most influential people in New York’s Capital Region during 2005, as selected by Visions magazine, the monthly publication of the Albany-Colonie Regional Chamber of Commerce.

well as in drug delivery will lead to tremendous advances in future medicines,” Dr. Mousa says. “Furthermore, using nanotechnology for site-directed delivery of specific medicine to cancer cells, ocular targets and vascular cells will also result in improved efficacy and safety profiles for future medicines.” The creation of the Preformulation and Stability Testing Laboratory in 2005 was a significant step in the Institute’s growth – the tip of the nanopharmaceutical iceberg at PRI. “Development of nanopharmaceutical products will greatly increase the efficacy and safety of drug therapies for diseases such as cancer – America’s No. 1 killer,” Dr. Mousa says. “We are proud to be on the forefront of such an important medical technology.”

Sciences for … seeing

How do we see the world? Through our eyes, in the most basic sense. But also in the way we interpret the images we see. Two ways of looking at things – one literal, one figurative. That is the connection between the seemingly disparate research of Rich Dearborn (page 5) and Ray Chandrasekara (page 6). Dr. Dearborn, in the Department of Basic and Pharmaceutical Sciences, studies minute changes in the eyes of common fruit flies, trying to determine how cells communicate and develop. When that process fails, disease states can arise. For Dr. Dearborn, the most critical part of this work is the translational connection to human applications and the potential for finding new cures. Dr. Chandrasekara’s translations are more traditional. His soon-to-be published English versions of the works of littleknown Indonesian and Malaysian authors will open up a whole new world to foreign audiences. In his classes in the Department of Humanities and Social Sciences, Dr. Chandrasekara applies his own experiences and background to help students interpret the works they are studying – to learn to understand people and see their world – in a deeper way. Sciences for seeing. 4

Flies. To most of us, they are pests. We swat them or shoo them away. Not Rich Dearborn. He gazes deep into their eyes, trying to unlock biomedical secrets about cell communication and development. “The beauty of what nature has dropped into our laps is fascinating,” he says.

“Studying this single line of communication can have enormous health implications,” he says. “Blood vessel growth, tumorgenesis, etc., all depend on the modulation of signaling cues. Many disease states arise as a result of a breakdown in cell communication.” The fruit fly’s eye, a marvel of precisely organized structural elements,

mutant line, she was able to narrow the approximately 14,000 fruit fly genes down to a region of the genome containing only a dozen relevant candidates. Once identified, “I can then plug that information into my research to fill in the gaps in our current understanding,” Dr. Dearborn says. “I am able to show my students

makes it ideal for this work. Even subtle changes can be detected easily. “Eph signaling is critical in eye-brain development,” says Dr. Dearborn, an Assistant Professor in the Department of Basic and Pharmaceutical Sciences. “When communication is not functioning properly, it is easy to tell – just look at the eye.” Because the process is not fully understood, Dr. Dearborn’s goal is to identify the genes associated with Eph signaling mutants, their roles in development and how they interact to form a functional signaling pathway. Students in Dr. Dearborn’s research lab use modern genetic, molecular and cell biology techniques to investigate these questions in a developmental context. Aimee Drew, a fourth-year student in the Doctor of Pharmacy program, spent the summer helping to map genes involved in Eph signaling. In one

how molecular biology is important to them as pharmacists, how candidate targets for drugs are identified,” he adds. “It’s not just in a textbook; I’m doing the research right now.” Dr. Dearborn is thriving in an environment at ACP that fosters innovative research. He currently is collaborating with Associate Professor Jeff Voigt, Ph.D., using the fly model to study a gene that is linked to breast cancer. “When you bring basic researchers together, that in itself sparks new ideas,” Dr. Dearborn says. “Students, faculty and colleagues talk to each other, that’s when things ignite and begin to take off.” Dr. Dearborn’s enthusiasm for his work and this collaborative environment comes through loud and clear. “It’s exciting to be a part of the College as it is growing and developing new programs,” he says.

The eyes have it Richard E. Dearborn Jr., Ph.D.

The fly of choice for Dr. Dearborn (Ph.D., State University of New York at Albany) is the tiny, pesky fruit fly. For the past seven years, including his postdoctoral research at Harvard University, he has focused his research efforts on cell communication through the study of the fruit fly’s crystalline, compound eye. “The basic tool kits for constructing cells are the same” whether you are looking at fruit flies, mice or humans, explains Dr. Dearborn, who joined the ACP faculty in 2004. This conservation of key components promotes translational research, where insights obtained in the fly have the potential for applications in humans. Dr. Dearborn’s research involves cell communication as mediated by receptors of the Eph family of tyrosine kinases. Signaling through Eph molecules is essential in vascular development, the wiring of brain circuitry and other processes that carry clear biomedical implications.

Ray Chandrasekara is bringing a new way of seeing the world to ACP. An Assistant Professor in the Department of Humanities and Social Sciences, his background, life experiences and research inform every class he teaches. “I can relate why the people and cultures of Southeast Asia live the way they do,” he says. “These are not merely

release and subsequent house arrest that Dr. Chandrasekara first visited him and began an enduring friendship. In 1999, Dr. Chandrasekara, along with colleagues from Berkeley, translated a collection of Pramoedya’s stories (Tales from Djakarta) that was published by Cornell University Press. Now Dr. Chandrasekara has been asked for his help

Chandrasekara explains. “Work by women writers rarely sees the light of day outside of the country.” The classroom is one of his most vital laboratories. “As always, my students are my first audience and best feedback for any translation. They are also my fiercest critics,” Dr. Chandrasekara says. ”Many

again. He is collaborating on a translation of Pramoedya’s Keluarga Gerilya (The Guerilla Family) and will have rights for its foreign publication. “The offer to translate another book is critical to the understanding of Pramoedya,” Dr. Chandrasekara says. “It’s important for the English reading public, and especially to the college classroom, as it exposes the role of Southeast Asian literature in the global context.” Another project, requested by the Malaysian government publishing house, is his translation of and critical introduction to an anthology of short stories by Malay women authors active from 193090. His translation will enrich world literature classes at ACP and throughout the United States by providing access to a group little known to foreign audiences. “The government of Malaysia is good about publishing women writers but men are most often translated,” Dr.

times I have merged their suggestions and comments and have found their integrity as readers to be staunch, and sometimes unnerving. But that is exactly what I need to be faithful to a translation.” Dr. Chandrasekara currently offers a class called Changing Images of Asia. He hopes to teach a class on AsianAmerica (the Asian immigrant diaspora and American-born Asians) and another on Literatures of Orientalism, with a primary focus on India and England that will include other colonial societies, notably colonization of the Philippines by the United States and Indonesia by the Dutch.

Global vision Ray Chandrasekara, Ph.D.

tools for teaching; this is how I grew up.” Dr. Chandrasekara (Ph.D., University of California, Berkeley) was born in Malaysia and raised during a turbulent time in Southeast Asia’s history. His primary area of interest, and one that carries over into his teaching, is the “nationalist voice” and political subtext in the literature of Malaysia and Indonesia, from 16th century Malay court chronicles to writings by contemporary authors such as Pramoedya Ananta Toer. The Indonesian novelist, short-story writer, essayist and critic is Southeast Asia’s most prominent author. Pramoedya has written often about his country’s struggle for independence. Imprisoned numerous times for his beliefs, his best-known work, the Buru Quartet, was penned while he was incarcerated on the notorious Buru Island following the establishment of the “New Order” by President Suharto. It was after Pramoedya’s 1979 6

Sciences for … solving

For pharmacists, the word solution usually brings to mind a homogeneous mixture of two or more substances. For Angela Dominelli (page 8) and Tom Lodise (page 9), it also means figuring out the answers to thorny problems. Though the issues they tackle are vastly different, searching for solutions to benefit health care providers and patients is a common theme in their work. Dr. Dominelli develops strategies to help those in pharmacy and other health-related businesses enhance services, save money and increase efficiency, which will allow them to provide better care. Finding solutions for providers that ultimately will benefit patients. Dr. Lodise strives to maximize the effectiveness of existing drugs – antibiotics, in particular – to improve patient outcomes, which will provide significant cost savings throughout the health care system. Finding solutions for patients that ultimately will benefit providers. Two approaches. Myriad solutions. One end – better, more affordable health care services. Sciences for solving. 7

Are we providing the right services? Are the most appropriate people in pharmacy and medical technology positions? Can we improve on the quality of services and make them more affordable? These are the questions that keep Angela Dominelli ’78 up at night. Dr. Dominelli (Ph.D., Union College) is immersed in the study of total quality

In the fall of 2004, she worked with Department of Pharmacy Practice faculty member Macary Weck, Pharm.D., to determine what was important to supermarket patrons in terms of pharmacy services. Their findings, which showed most preferred basic services over “glitzy” offerings such as 24-7 hours and drive-thru windows, will help supermar-

Questions of quality Angela C. Dominelli ’78, Ph.D.

management in the provision of health care. It is a complex network of services, providers and professionals with a wide array of skills and expertise. “Pharmacy is just one piece of the puzzle. I can’t divorce myself from other aspects of health care,” says Dr. Dominelli, whose academic interests also relate to health care administration and pharmacy administration. Dr. Dominelli, a registered pharmacist who earned a B.S. in Pharmacy at ACP, always has had an affinity for the “business side” of things. With a Ph.D. in Administrative and Engineering Sciences and her MBA from Union College, she is ideally suited to her work as an Assistant Professor of Pharmacy Administration in the Department of Humanities and Social Sciences. With myriad research projects recently completed or in the works, Dr. Dominelli is juggling lot of balls these days. 8

ket pharmacies attract new customers. Another study, undertaken with M. Elyse Wheeler, Ph.D., Associate Dean for Graduate and Extension Programs, examined the personality traits of 60 medical technologists employed in a variety of clinical settings. Currently, the med tech field is having a difficult time attracting and keeping people, explains Dr. Dominelli. The results, to be published in the Journal of Allied Health, will help develop a new approach that will have tremendous significance in terms of work paradigm and recruitment and retention of those entering and working in the field, she adds. Dr. Dominelli’s work with Hudson Headwaters Health Network, a community care network that serves northern New York State, has had a positive impact through the use of an alternative model of a long-standing federally funded drug program. By saving money on phar-

maceuticals, the health plan has been able to increase access to prescription drugs for its patients and apply the cost savings to provide other desperately needed services, including dental clinics and increased pediatric staffing. Other research has focused on the influence of pharmacy education on students’ knowledge and attitudes toward pharmaceutical advertising; the comparison of service quality preferences of consumers utilizing community and Internet pharmacies; and the creation of a tested survey instrument that can be used to measure a patient’s knowledge of anticoagulation therapy. “It’s all about quality,” Dr. Dominelli says. Dr. Dominelli also serves on the Board of Directors of the International Business and Health Care Administration. “It keeps me in the forefront,” she says.

Resistance to antibiotics is on the rise. Research and development into new antibiotics has become stagnant. You do the math. Tom Lodise does. In the face of this dilemma in the treatment of infectious diseases, Dr. Lodise (Pharm.D., Temple University) is studying new ways to use old drugs more effectively. By applying mathemat-

that there are not many antibiotics under development.” Since 1998, only 10 new antibiotics have been approved, and only two of those are truly novel, according to Dr. Lodise. In 2002, among 89 new medicines emerging on the market, none was an antibiotic. Dr. Lodise’s current research

and serve as an intervention to improve outcomes, minimize resistance development and reduce treatment costs. Dr. Lodise currently is implementing his epidemiologic and outcomes research proposals at the Stratton VA Medical Center and Albany Medical Center Hospital, and also collaborates extensively with the Ordway Research Institute. Since he joined the ACP faculty in 2002, he has been involved in more than a dozen original research projects focused on these critical themes. “Thus far, the results are very promising,” Dr. Lodise says. “We have identified several dosing schemes and antibiotic regimens that are associated with superior patient outcomes and have improved patient survival rates.”

It all adds up Thomas P. Lodise, Jr., Pharm.D.

ical modeling, he analyzes current dosing regimens, predicts the effectiveness of new dosing methods and designs drug regimens that maximize the effects and minimize the development of resistance. “Antibiotic resistance is dramatically increasing in both the hospital and community setting,” Dr. Lodise says. “In U.S. hospitals, there are over 2 million infections each year, and more than half are caused by antibiotic-resistant organisms.” It is estimated that antibiotic resistance contributes to more than 77,000 deaths and $5 billion-$10 billion in costs each year in the United States alone. “More alarmingly,” Dr. Lodise notes, “there is rising prevalence of infections for which there are no effective antibiotics, or we have to resort to antibiotics that have not been used in 30 years because they are highly toxic. This situation is further complicated by the fact

endeavors focus on the epidemiology of bacterial infections and the relationship between antimicrobial exposure and patient outcomes. He is keenly interested in optimizing outcomes of infections by the use of pharmacokinetic and pharmacodynamic principles. Over the past 20 years, there have been tremendous strides in understanding the relationship between antimicrobial exposure and microbiologic response. Specifically, the drug exposure, or pharmacodynamic target, associated with maximal effect has been identified for various antibiotics. With advances in computer technology and mathematical modeling, it now is possible to generate antibiotic dosing schemes that maximize the probability of achieving the pharmacodynamic target of interest, thus ensuring the highest likelihood of a successful outcome. Once a more optimal dosing regimen is identified, it can be applied in clinical practice 9

Sciences for … saving

The top two killers in the United States are cardiovascular disease and cancer. Adwoa Nornoo (page 11) and Bob Hamilton (page 12) are working to improve those statistics. Though they approach the problem from different angles and in very different settings, their work is connected by their ultimate goal – to help people affected by these diseases live better and longer lives. Cardiovascular disease is Dr. Hamilton’s target. He sifts through voluminous data in a cubicle at the New York State Office of Medicaid Management, trying to determine if low-income Medicaid recipients are getting the most appropriate regimen of drugs. Ultimately, the information will be used to maximize the benefits of drug therapies for those with congestive heart failure. At her laboratory bench in ACP’s Pharmaceutical Research Institute building, Dr. Nornoo pours her research efforts into a novel formulation of an anti-cancer agent, striving to expand its usefulness and bring immediate benefits to patients with breast, lung and ovarian cancer. Sciences for saving.

Like oil and water Adwoa O. Nornoo, Ph.D.

Oil and water don’t mix. It’s one of the most basic facts of science. Or is it? Adwoa Nornoo is researching new ways to blend these ardently antisocial liquids in orally delivered microemulsions that could improve the treatment of breast, lung and ovarian cancer, as well as the HIV-related disease Kaposi’s sarcoma. “As a pharmaceutical scientist involved in novel drug-delivery systems, I am most interested in research that contributes directly to improvements in drug therapy, where one can immediately see the benefit to the patient,” says Dr. Nornoo (Ph.D., University of Houston), an Assistant Professor in the Department of Basic and Pharmaceutical Sciences. Dr. Nornoo first became interested in research on intravenous microemul-

sions containing the anticancer agent paclitaxel during her time in graduate school. She has continued that work since joining the ACP faculty in 2002. However, although the drug has shown impressive clinical results against solid malignancies, the currently used IV dosage form has its limitations. Paclitaxel is not water-soluble, so it is not absorbed in high enough quantities to be effective if given orally, says Dr. Nornoo. It also can cause hypersensitivity reactions in some patients, requiring the co-administration of antihistamines. Oral microemulsions, on the other hand, possess unique characteristics that make them ideal formulation candidates for drugs that are poorly aqueous soluble and have low permeability, such as paclitaxel. They do not separate into oil and water over time, as opposed to emul-

sions, making the formulation much more stable. To develop a microemulsion containing paclitaxel, Dr. Nornoo is utilizing a surface active agent, or surfactant, to help mix the oil and water and thus increase absorption of the drug. Paclitaxel also has a high affinity for drug transporters such as p-glycoproteins, which occur naturally in the body to prevent toxic substances from being absorbed but create another problem for the drug in its oral form. Because surfactants inhibit p-glycoproteins, Dr. Nornoo believes this could help overcome the limitations of the current therapy. “My goal is not only to develop drug microemulsion formulations, but to understand how they work to further improve the quality and, perhaps, expand the usefulness of this type of novel drugdelivery system,” she says.

Bob Hamilton ’77 has tapped a large, comprehensive data source to positively impact the lives of tens of thousands of patients in New York State with congestive heart failure. Dr. Hamilton (Pharm.D., Virginia Commonwealth University) has delved deep into the storehouse of patient information available from the New York State Office

Hamilton’s longtime research focus on drug therapies for patients with cardiovascular disease, and his work in epidemiology and behavioral health policy issues. While most ACP faculty also work at practice sites such as hospitals or other patient care settings, Dr. Hamilton works with the DUR Board on conducting retrospective drug utilization reviews and

Of hearts and minds Robert A. Hamilton ’77, Pharm.D.

of Medicaid Management to assess and improve the use of drug therapies in the Medicaid population. He also has worked for several years with the New York State Drug Utilization Review Board. “The goal of legislation authorizing the Medicaid DUR Board is to educate providers and to improve patient outcomes,” says Dr. Hamilton, Professor and Department Manager in the Department of Pharmacy Practice. “We have progressed toward that goal using many traditional means, but are now considering whether other methods might improve our results. “There is a great deal of data available that can show us how we should treat patients so they stay healthier longer, stay in their homes longer and live longer. We’re trying to maximize the benefits of drug therapies by making sure that everyone that needs or could benefit from a drug is receiving it.” The project is a natural fit for Dr. 12

using those results to improve health outcomes for the 4 million low-income Medicaid recipients statewide. Dr. Hamilton decided to use the data collected in those reviews to analyze the treatments being used for patients with congestive heart failure, who accounted for more than 35,000 hospital admissions in 2003 alone. He took a sabbatical from July 2004 to January 2005 to research whether these patients are receiving the recommended drug therapies and doses and to determine if the pattern of drug usage has changed. ACE inhibitors are the traditional drug therapy for congestive heart failure, but in the past decade beta blockers have proven an effective therapy as well. Dr. Hamilton found that in calendar year 2003 about half of the patients studied received ACE inhibitors within 30 days of hospital discharge, which had not changed significantly from 2000, while the use of beta blockers increased significantly.

However, only about 20 percent of the population received both drugs. Treatment guidelines say that, barring other complications such as asthma or kidney dysfunction, congestive heart failure patients should be on both drugs to improve their quality of life and reduce hospitalizations. “Though complications may account for some recipients not receiving both therapies, the number receiving both was still disappointingly low,” he says. So Dr. Hamilton designed an intervention strategy to improve that number by increasing awareness among physicians and patients. He first published an article in the Medicaid Update newsletter to inform health care providers about the drug therapy statistics. His next step is to send letters to congestive heart failure patients letting them know that there are additional drugs that could help them, and encouraging them to consult with their doctor and visit Web sites such as the American Heart Association (www.americanheart.org) for treatment guidelines and available drug therapies. Dr. Hamilton also plans to send letters to physicians about the treatment statistics and intervention strategy, then follow up three to six months later to assess the effectiveness of the campaign.

Sciences for … discovery

“You can know the name of a bird in all the languages of the world, but when you’re finished, you’ll know absolutely nothing whatever about the bird. ... So let’s look at the bird and see what it’s doing – that’s what counts. I learned very early the difference between knowing the name of something and knowing something.” –Richard Feynman (educator, physicist; 1918-1988) One of America’s foremost scientists, Dr. Feynman understood well the connection between learning in the traditional classroom style and having an opportunity to independently pursue and challenge established facts in a research setting. At ACP, we also understand this important connection and the valuable products that arise from active learning. A mind prepared to think critically. A complete academic experience. Knowledge. Whether it relates to drug development at the laboratory bench or in better understanding of medications delivered at a hospital bedside, research is a fundamental component of an ACP education. Sciences for discovery.

At most colleges, undergraduate students learn about other people’s research and ask, “why?” At ACP, they also get to dream up their own research projects and ask, “why not?” Research, both in the laboratory and in clinical and community settings, is an integral and invaluable component of the educational experience at ACP. In this

available, as well as a wide range of clinical and community opportunities. The research component is a critical part of ACP’s Pharmaceutical Sciences program. Students participate in significant lab-based course work for all four years, with seniors required to take two three-credit research classes that span both semesters. Seniors generally spend

Research rocks! Undergraduate opportunities

new era of health care, with an emphasis on critical thinking and problem solving, the research that reinforces these skills has become increasingly important. “Scientists get to do this type of work, but students don’t often have the opportunity,” says David Clarke, Ph.D., Director of the Pharmaceutical Sciences Program. “In more traditional college courses, they are just reproducing results, as opposed to doing something unique and innovative. “A lot of the stuff our students are doing in the lab here is really cool. To answer a question that no one else has, or, better yet, to ask a question that no one has asked and uncover the answer – that’s fun.” Students pursuing a Bachelor of Science in Pharmaceutical Sciences find a particularly strong focus on laboratory research as part of the academic experience. Students in the Doctor of Pharmacy program have similar opportunities 14

6-9 hours per week on research, do an oral presentation and write up their research in a scientific journal format during the Spring semester. “One of the goals of the Pharmaceutical Sciences program is to help students develop thinking skills consistent with a scientist’s,” says Dr. Clarke. “Classroom activities alone don’t foster that. Here, they can go from thinking ‘this is how my mentor would do it’ and transition into doing ‘real science’ themselves.” While some students assist faculty with their research – “answering one small question that is part of a bigger question,” Dr. Clarke says – others complete work that is related but can stand on its own. Holly Bean, a freshman in the Pharmaceutical Sciences program, is looking forward to conducting her first research project at ACP. A bee keeper, she plans to investigate the anti-bacterial agents of honey.

“This opportunity is very exciting to me, because I can dream big and do it, which normally would never happen for a student in their freshman year,” she says. “I’ll get to explore my own area of interest and learn about the scientific process at the same time.” Shaarika Sarasija, who also started in the Pharmaceutical Sciences program this fall, was offered a scholarship to ACP at the prestigious 2005 Intel International Science and Engineering Fair, where she presented her research on the successful use of wild asparagus to increase milk yield in goats. Shaarika, who came to Albany from her native India, plans to continue her research at ACP, concentrating on identifying the active component in the vegetable. “I think I landed in a really good spot at ACP,” says Shaarika. “If I had stayed in India, I would have had to wait until I got my Master’s degree to pursue research. In the BSPS program I will be allowed to carry out my research as early as my second semester under the guidance of a superb faculty.” In addition to their lab work, students in the program have the opportunity to work with faculty mentors in eightweek summer research internships or in an Independent Study over the course of the academic year. There are also sixweek research fellowships available to all ACP students in Hiroshima, Japan, with Maruzen Pharmaceuticals, manufacturers of a variety of natural products with medicinal uses. The Pharmaceutical Sciences program makes a great stepping stone to research in graduate school or an industrial setting, Dr. Clarke says. Graduates are equipped to pursue further education or research in business, medical, dental, veterinary and law programs.

A summer spent in an ACP research laboratory helped bring a new career path into focus for Brian Myer. A third-year student in the Bachelor of Science in Pharmaceutical Sciences program, Brian has broadened his goals. He still has plans to continue on to medical school after graduation, but would like to add in a research compo-

clinic. It also gave him a dual purpose for his career aspirations. “Ideally, I would like to practice medicine and do research further down the road,” he says. Working with Dr. Nornoo, Brian’s role included the use of high-performance liquid chromatography to determine the concentration of paclitaxel in

to drugs and how drugs react to the body,” he explains, noting that he is eager to take upcoming courses in biopharmaceutics and drug formulation. “I see a huge benefit from my classes at ACP,” he says. “Many doctors have too much they have to know and don’t have time to understand the drugs they prescribe. My work here will make me a better physician.”

Career change Brian Myer ’07, B.S., Pharmaceutical Sciences

nent in the future. “My research allowed me to appreciate the work of people who develop drugs,” he says. “To me, seeing what you can do as a research scientist – the thinking part of it – is what is exciting.” Brian spent the dog days of summer as a research intern for Adwoa Nornoo, Ph.D., Assistant Professor in the Department of Basic and Pharmaceutical Sciences. Their objective is to develop an oral formulation for paclitaxel, which is representative of many anticancer drugs. “They are huge molecules that are hard to infuse,” Brian explains. “We are using microemulsions to deliver the drug, as this sort of formulation has shown great promise.” The valuable hands-on research experience complemented the volunteer work Brian does in the Albany Medical Center emergency room and at the Capital City Rescue Mission’s free

solution. He also used cell culture and in situ animal surgery techniques to measure the absorption of paclitaxel across the small intestine, where most drugs are absorbed. Brian will continue to do in vitro research on the drug’s transport using Caco-2 cells taken out of the human small intestine, growing them in plates with permeable inserts to form a monolayer similar to the first layer of cells in the small intestine. “We put paclitaxel on one side of the membrane to see how it diffuses to the other side and how much is absorbed,” he says. The work expanded Brian’s exposure to critical skills such as problem solving and scientific reporting in a research environment, Dr. Nornoo says. The hands-on experience also enhanced his understanding of his coursework and piqued his curiosity, Brian adds. “I want to see how the body reacts 15

Nimish Patel has spent the past year poring over patient records and crunching numbers to study a new antibiotic dosing regimen adopted at Albany Medical Center Hospital that may yield improved patient outcomes and reduced treatment costs. A sixth-year Doctor of Pharmacy student, Nimish joined the study for a

Nimish continued his work with Dr. Lodise in the summer of 2005. “We have reached the most exciting stage of this project – we are analyzing the data and will soon be able to draw conclusions and make reports about the use of these treatments for hospitalized patients,” Nimish says. “Often research such as this influences

Safety in numbers Nimish Patel ’06, Doctor of Pharmacy summer research project in 2004 to assist project director and faculty mentor Tom Lodise, Pharm.D., an Assistant Professor in ACP’s Department of Pharmacy Practice. The study used new mathematical modeling techniques that combine pharmacokinetic and pharmacodynamic parameters to evaluate the clinical and cost effectiveness of a new extended infusion dosing regimen adopted at Albany Med for patients with certain resistant bacterial infections. Nimish was a quick study on his first clinical research experience, learning data collection techniques, database management and data analysis. “Nimish also identified additional data elements for collection that improved the quality of the study,” says Dr. Lodise, who was so impressed with Nimish’s contributions that he hired him to continue working on the project throughout the 2004-05 academic year. 16

therapeutic decisions for future patients with the same infections.” Nimish, who plans to pursue a residency in infectious disease research after graduation in May, also conducted, for a seminar course, an ambitious study of a new dosing paradigm for a class of antibiotic drugs used to treat community-acquired pneumonia. He used the advanced mathematical modeling techniques he learned from Dr. Lodise to determine that a new dosage of antibiotics can treat patients faster, more effectively and for less cost. “I enjoy working on antibiotics,” Nimish says. “It’s satisfying to know that developing new treatment regimens can diminish the frequency and severity of opportunistic infections and lead to healthier outcomes for patients and the general population.” He shares that source of satisfaction with Dr. Lodise, whose research focuses on the epidemiology of bacterial

infections and optimal use of antibiotics to improve patient outcomes and minimize antibiotic resistance. “Nimish has become a vital part of my research program and has assumed a more active role in study coordination and the training of future students participating in my research endeavors,” Dr. Lodise says. “Professor Lodise is not only an excellent mentor and teacher, he is a leader in health care,” Nimish says. “It is impressive to work with someone who is so involved and has such a positive influence on the world of infectious disease research. “Seeing him in action only makes me want to achieve the same, and strive for more.”

ACP’s seventh annual High School Summer Enrichment Program allowed four Albany High School students an opportunity to gain first-hand experience in a research setting, studying bladder function and blood clotting in addition to receiving a well-rounded introduction to college and industry environments. Morgan Moore, an Albany High sen-

students’ research work was noteworthy, Dr. Clarke says. “The faculty were impressed with the research results the students presented,” he says. “You would have been hard-pressed to distinguish the posters that they produced from other undergraduate research posters.” Initiated in 1999 and merged with

also was available to ACP students conducting separate summer research projects. Martha Hass, Ph.D., Chair of the Department of Basic and Pharmaceutical Sciences, lectured on lead compound identification and testing. Adwoa Nornoo, Ph.D., of the Department of Basic and Pharmaceutical

A jump start on research High School Summer Enrichment Program

ior in 2005-06, and Marvin Lewis, who graduated in June, worked with Department of Basic and Pharmaceutical Sciences faculty member Robert Levin, Ph.D., on a project entitled “The Effects of Hydrogen Peroxide on Citrate Synthase Activity Obtained from Normal and Obstructed Urinary Bladder Muscle and Mucosa.” Nimmy David and Avjola Hoxha, both current Albany High seniors, worked with Pharmaceutical Research Institute Executive Vice President and Chairman Shaker Mousa, Ph.D., on a project entitled “Antithrombotic Effects of Natural Products in Combination with Anticoagulant Drugs.” David Clarke, Ph.D., Director of ACP’s Pharmaceutical Sciences Program, organized the six-week summer program, which also included outings to medical and research facilities in the Capital Region and, for the first time, a Drug Development Lecture Series. The

the City of Albany’s Summer Institute for Career Exploration in 2004, the summer enrichment program offers a unique opportunity for students who possess a potential to excel, an interest in science and a desire to learn scientifically based problem-solving skills. The program provides educational enrichment and support activities in small group settings through hands-on pharmaceutical sciences projects and research experiences. On a weekly basis, the students spend three days participating in research with an ACP faculty member – Drs. Levin and Mousa in 2005 – one day conducting literature reviews related to their research experience, and one day on field experiences. This summer’s outings included Albany Medical Center research facilities, Albany Molecular Research Inc., Regeneron Pharmaceuticals Inc. and Organichem Corp. The new Drug Development Lecture Series, presented by ACP faculty,

Sciences, lectured on preformulation and formulation. Patrick Meek, Pharm.D., of the Department of Pharmacy Practice, lectured on clinical trials. Leon Cosler, Ph.D., of the Department of Humanities and Social Sciences, lectured on post-market monitoring and related issues. The combination of experiences ACP provides allows participants to gain valuable research experience and explore career opportunities in the pharmaceutical sciences. “Working at the College was a great opportunity and learning experience,” Lewis said. “I enjoyed the research that I did there and gained a lot of knowledge about that topic.”

Scholarly activity | Pharmaceutical Research Institute

Publications Shaker Mousa Mousa SA and Johansen K. Pharmacodynamic effects of low molecular weight heparin in obese subjects following subcutaneous administration of 75 IU/kg on plasma tissue factor pathway inhibitor and nitric oxide. International Angiology: A Journal of the International Union of Angiology 24(1):40-42, March 2005. West SG, Hilpert KF, Juturu V, Bordi PL, Lampe JW, Mousa SA and KrisEtherton PM. Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy. Journal of Women’s Health: The Official Publication of the Society for the Advancement of Women’s Health Research 14(3):253262, April 2005. Mousa SA. Alpha v integrin affinity/ specificity and antiangiogenesis effect of a novel tetraaza cyclic peptide derivative, SU015, in various species. Journal of Cardiovascular Pharmacology 45(5):462-467, May 2005. Mousa SA, Mohamed S, Wexler EJ and Kerr JS. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist. Anticancer Research 25(1A):197-206, January/ February 2005. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa SA and Davis PJ. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146(7):2864-2871, 2005.

Mousa SA, Bozarth JM, Seiffert D and Feuerstein GZ. Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis 16(3):165-171, April 2005. Mousa SA. Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix-degrading enzyme aggrecanase: Structure-function relationship. Journal of Cellular Biochemistry 95(1):95-98, May 2005. Mousa SA and Stoller GL. Angiogenesis, choroidal neovascularization, and the coagulation system. Retina 25(1):19-25, January 2005. Mousa SA and Mohamed S. Human alphavbeta3 integrin potency and specificity of TA138 and its DOTA conjugated form (89)Y-TA138. Journal of Cardiovascular Pharmacology 45(2):109-113, February 2005. Mousa SA. Emerging links between thrombosis, inflammation, and cancer: Role of heparin. Acta Chirurgica Belgica 105:1-12, 2005. Mousa SA and Kaiser B. Tissue factor pathway inhibitor in thrombosis and beyond: Role of heparin. Drugs of the Future 29(7):751, 2004. Abdel-Razeq H and Mousa SA. Thalidomide: a new old drug in the treatment of multiple myeloma. Drugs of the Future 29(10):1059, 2004. Mousa SA. Anti-thrombotics in thrombosis and cancer. Future Oncology 1(3):395-403, June 2005.

Mousa SA. Low-molecular-weight heparins in thrombosis and cancer: Emerging links. Cardiovascular Drug Review 22(2):121-134, 2004.

Mousa SA and Mousa AS. Angiogenesis inhibitors: Current & future directions. Current Pharmaceutical Design 10(1):1-9, 2004.

Mousa SA and Mohamed S. Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: Anti-cancer efficacy. Oncology Report 12(4):683-688, 2004.

Mousa SA. Cell adhesion molecules: potential therapeutic and diagnostic implications. Methods in Molecular Medicine 93:157-174, 2004.

Mousa SA and Mohamed S. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor. Thrombosis and Haemostasis 92(3):627-633, September 2004. Pawar P, Shin PK, Mousa SA, Ross JM and Konstantopoulos K. Fluid shear regulates the kinetics and receptor specificity of Staphylococcus aureus binding to activated platelets. Journal of Immunology 173(2):12581265, July 2004. Davis FB, Mousa SA, O’Connor L, Mohamed S, Lin HY, Cao HJ and Davis PJ. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circulation Research 94(11):1500-1506, 2004. Ali SH, O’Donnell AL, Mohamed S, Mousa SA and Dandona P. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: Inhibition of growth and angiogenic factors. Gynecologic Oncology 95(3):637-645, December 2004. Shahan T, Grant D, Tootell M, Ziaie Z, Ohno N, Mousa S, Mohamad S, Delisser H and Kefalides N. Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis. Connective Tissue Research 45(3):151-163, 2004. Mousa SA. Arixtra (Fondaparinux sodium). Methods in Molecular Medicine 93:239-246, 2004. Mousa SA. Low-molecular-weight heparins in thrombosis and cancer: Emerging links. Cardiovascular Drug Review 22(2):121-134, 2004. Mousa SA, Fareed J, Iqbal O and Kaiser B. Tissue factor pathway inhibitor in thrombosis and beyond. Methods in Molecular Medicine 93:133-155, 2004.

Mousa SA. Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases. Methods in Molecular Medicine 93:35-48, 2004. Mousa SA. Tissue factor/VIIa in thrombosis and cancer. Methods in Molecular Medicine 93:119-132, 2004. Abdel-Razeq H, Qari M, Kristensen J, Alizeidah H, Al-Sayegh F, Marashi M, Alzeer A, Al-Amoudi O, Qutub H, AlHumiadi AA, Husted S and Mousa SA; GCC Thrombosis Study Group. Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Methods in Molecular Medicine 93:267-292, 2004. Mousa SA. Oral thrombin inhibitor ximelagatran. Methods in Molecular Medicine 93:247-251, 2004. Mousa SA. Low-molecular-weight heparin in thrombosis and cancer. Seminars in Thrombosis and Hemostasis 30(Supplement 1):25-30, February 2004. Iqbal O and Mousa SA. Antiplatelet, anticoagulant, and thrombolytic drug interactions. Methods in Molecular Medicine 93:9-20, 2004. McCarty OJ, Abulencia JP, Mousa SA and Konstantopoulos K. Evaluation of platelet antagonists in in vitro flow models of thrombosis. Methods in Molecular Medicine 93:21-34, 2004. Mousa SA. Are low molecular weight heparins the same? Methods in Molecular Medicine 93:49-59, 2004. Smallheer JM, Weigelt CA, Woerner FJ, Wells JS, Daneker WF, Mousa SA, Wexler RR and Jadhav PK. Synthesis and biological evaluation of nonpeptide integrin antagonists containing spirocyclic scaffolds. Bioorganic & Medicinal Chemistry Letters 14(2):383-387, January 2004. Mousa SA. Highlights of latest advances in antithrombotics. Methods in Molecular Medicine 93:1-7, 2004.

Scholarly activity | Basic and Pharmaceutical Sciences

Publications Prashant J. Chikhale Rautio J and Chikhale PJ. Drug delivery systems for brain tumor therapy. Current Pharmaceutical Design 10:1341-1353, 2004.

Parekh MH, Chichester PC, Lobel RW and Levin RM. Effects of castration on female rabbit bladder physiology and morphology, Urology 64(5):10481051, November 2004.

Sliesoraitis S and Chikhale PJ. Carboplatin hypersensitivity. International Journal of Gynecological Cancer 15(1):13-18, January-February 2005.

Levin RM, Whitbeck C, Horan P and Bellamy F. Low-dose Tadenan® protects the rabbit bladder from bilateral ischemia/reperfusion-induced contractile dysfunction, Phytomedicine 12(1-2):17-24, January 2005.

Richard E. Dearborn Jr. Dearborn Jr., RE and Kunes S. An axon scaffold induced by retinal axons directs glia to destinations in the Drosophila optic lobe. Development 131(10):2291-2303, May 2004.

Agartan CA, Whitbeck C, Leggett RE, Chichester PC and Levin RM. Protection of urinary bladder function by grape suspension. Phytotherapy Research 18(12):1013-1018, December 2004.

Martha A. Hass Moon D and Hass MA. Herbal Products and Botanicals: Opportunities and Concerns in Pharmacy Practice for Technicians, 3rd edition, (Sr. Jane Durgin, Zachary Hanan and Janet Mastanduno, eds), Delmar Publishers (Thompson Publishing Co), Albany, N.Y., 2005.

Agartan CA, Whitbeck C, Chichester PC, Kogan BA and Levin RM. Effect of age on rabbit bladder function and structure following partial outlet obstruction. The Journal of Urology 173(4):1400-1405, April 2005.

Robert Levin Chou EC, Whitbeck C, Borow A, Burden O and Levin RM. Inhibition of hyperreflexia by vaginal administered oxybutynin: A novel rabbit model. The Journal of Urology 171(2, Pt. 1):958962, February 2004. Valentini FA, Levin RM, Besson GR and Nelson PP. Study of detrusor dysfunction due to outlet obstruction: Link between analysis of uroflows of men with benign prostatic hyperplasia and animal studies. Advances in Experimental Medicine and Biology 539(Part A):297-309, 2003. Matsumoto S, Levendusky MC, Longhurst PA, Levin RM and Millington WR. Activation of mu opioid receptors in the ventrolateral periaqueductal gray region inhibits volume-evoked micturition. Neuroscience Letters 363:116-119, June 2004. Levin RM, Leggett RE, Whitbeck C, Murakami T, Kambara T and Aikawa K. Oral Kohki tea and its protective effect against in vitro ischemic damage to the bladder. Neurourology and Urodynamics 23(4):355-360, 2004. Matsumoto S, Hanai T, Yoshioka N, Ohnishi N, Kurita K and Levin RM. Effect of timing of diuresis on response of rat bladder to outlet obstruction Urology 64(3):608-510, September 2004.

Levin RM, Danek M, Whitbeck K and Haugaard N. Effect of ethanol on the response of the rat urinary bladder to in-vitro ischemia: Protective effect of alpha-lipoic acid. Molecular and Cellular Biochemistry 271(1-2):133–138, March 2005.

Anita S. Mannikarottu Mannikarottu AS, Di Santo ME, Zederic SA, Wein AJ and Chacko S K. Regional variations in the expression of myosin isoforms, the molecular motor for smooth muscle contraction, in response to partial outlet obstruction. The Journal of Urology 173(1):302-308, January 2005.

Levin RM and Hudson AP. The molecular genetic basis of mitochondrial malfunction in bladder tissue following outlet obstruction. The Journal of Urology 172(2):438-447, August 2004.

Mannikarottu AS, Kogan B and Levin RM. Ischemic etiology of obstructive bladder dysfunction: A review. Recent Research Developments in Molecular and Cellular Biochemistry (Research Signpost) 2:15-34, June 2005.

Levin RM, Chichester PC, Levin SS and Buttyan R. Role of angiogenesis in the bladder’s response to partial outlet obstruction: A review. Scandinavian Journal of Urology and Nephrology Supplementum 215:3747, 2004.

William R. Millington Cavun S, Göktalay G and Millington WR. The hypotension evoked by visceral nociception is mediated by delta opioid receptors in the periaqueductal gray. Brain Research 1019(1-2):237-245, September 2004.

Uvelius B, Levin RM and Longhurst PA. Regulation of bladder function. Pathology of the Urinary Bladder (Christopher S. Foster and Jeffrey S. Roth, eds), Saunders, Philadelphia, Pa.:35-47, 2004.

Göktalay G, Levendusky MC and Millington WR. Muscimol injection into the lateral hypothalamus inhibits the hypotension and bradycardia caused by somato-visceral nociception. Brain Research 1029:124-130, December 2004.

Yu HJ, Chien CT, Lai YJ, Lai MK, Chen CF, Levin RM and Hsu SM. Hypoxia preconditioning attenuates bladder overdistension-induced oxidative injury by up-regulation of Bcl-2 in the rat. The Journal of Physiology 554 (Pt. 3):815-828, February 2004.

Gail G. Snitkoff Goodman-Snitkoff G. Biological Testing (Chapter 31). Remington’s Pharmaceutical Sciences 21st Edition, (A.R. Gennaro et. al., eds), Mack Publishing Company, Philadelphia, Pa.: 2005.

Jean Taylor Taylor J. Incorporating new technologies into the cytotechnology curriculum: Using experiential learning, including distance learning activities and case study materials-A game plan for getting started. Turning Experience into Instructional Excellence: Essays for Cytotechnology Educators (Cytotechnology Program Review Committee Handbook, Marilee Means, chair): 35-41, November 2004. Taylor J. The cytotechnology profession and the Cytotechnology Advisory Committee: Embracing change, seizing opportunity. American Society of Cytopathology Bulletin XLII (2):3235, 39, March 2005. HaiAn Zheng Zheng H, Zhao J, Wang S, Lin CM, Chen T, Jones DH, Ma C, Opella S and Xie XQ. Biosynthesis and purification of a hydrophobic peptide from transmembrane domains of G-proteincoupled CB2 receptor. The Journal of Peptide Research: Official Journal of the American Peptide Society 65(4):450-8, April 2005. Xie XQ, Zhao J and Zheng H. Expression, purification, and isotope labeling of cannabinoid CB2 receptor fragment, CB2(180-233). Protein Expression and Purification 38(1):61-8, November 2004.

Bold – denotes ACP faculty collaborating on a project

Basic and Pharmaceutical Sciences, cont’d.

Grants Robert Levin Project: Biomarkers predicting the severity of obstruction-induced bladder dysfunction Sponsor: Veterans Administration Merit Review Grant Current period: $140,000 Project period (2001-2005): $560,000 Project: Ischemic etiology of obstructive bladder dysfunction Sponsor: National Institutes of Health Co-investigator: Martha Hass Current period: $288,570 Project period (2004-08): $1,154,280 Project: Protective effect of grape suspensions on obstructive bladder dysfunction Sponsor: California Table Grape Commission Current period: $25,000 Project period (2003–05): $50,000 Project: Role of nitric oxide on the acute response of the rabbit to partial outlet obstruction Sponsor: Yamaneuchi USA Research Foundation Current period: $30,000 Project period (2003–05): $30,000 William Millington Project: Pharmacotherapy for opiate addiction and toxicity Sponsor: National Institute on Drug Abuse Current period: $38,000 Project period (2005–06): $90,929 Jeffrey M. Voigt Project: Modulation of AP-1 activity in human breast cancer cells by 1,25 Dihydroxyvitamin D3, VDUP-1, and Thioredoxin Sponsor: Blythe Grant, Albany College of Pharmacy Current period: $10,000 Project period (2004-05): $20,000

Abstracts/Presentations Richard E. Dearborn, Jr. Dearborn Jr. RE, Gray J and Kunes S. Plexin-B-mediated retinal axon target selection in the developing Drosophila visual system. Society for Neuroscience 35th Annual Meeting, Washington, D.C., November 2005. Martha A. Hass Siflinger-Birnboim A, Conners W, Levin RM and Hass MA. Partial bladder outlet obstruction-induced protein oxidation in the rabbit bladder. Experimental Biology 2005, San Diego, Calif., April 2005.

Hass MA, Levin RM, Conners W and Siflinger-Birnboim A. Protein oxidation following partial bladder outlet obstruction. American Urological Association, San Antonio, Tex., May 2005.

Goktalay G, Levendusky M, Cavun S, Hamilton J and Millington WR. Hemorrhage induces Fos expression ßendorphin neurons. Experimental Biology 2005, San Diego, Calif., April 2005.

Robert Levin Levin R. Protein nitration occurs in the acute response of the rabbit bladder to partial outlet obstruction. American Urological Association, San Antonio, Tex., May 2005.

Adwoa O. Nornoo Nornoo AO and Szwarcberg L. In-situ permeability of Paclitaxel across rat gastrointestine from oral microemulsions. 31st Annual Meeting and Exposition of the Controlled Release Society, Honolulu, Hawaii, June 2004.

Levin R. Effect of age on the response of the rabbit bladder to bilateral in vivo ishemica/reperfusion. American Urological Association, San Antonio, Tex., May 2005. Levin R. Effect of ethanol on the protection of urinary bladder function by grape suspensions. American Urological Association, San Antonio, Tex., May 2005. Levin R. Bladder smooth muscle cell phenotypic changes and detrusor functional changes on ischemiareperfusion injury in the rat urinary bladder. American Urological Association, San Antonio, Tex., May 2005. Levin R. Effect of strip length on the contractile dysfunction of bladder smooth muscle following partial outlet obstruction. American Urological Association, San Antonio, Tex., May 2005. Levin R. Protein oxidation following partial bladder outlet obstruction. American Urological Association, San Antonio, Tex., May 2005. Levin R. Development of a novel rabbit bladder cancer model for endoscopic evaluation of intravesical and intralesional therapies: A preliminary report. American Urological Association, San Francisco, Calif., May 2004. Levin R. Intravesical Ketoprofen inhibits acetylcholine-evoked urinary bladder contractility and hyperreflexia in the anesthetized rabbit model. American Urological Association, San Francisco, Calif., May 2004. William R. Millington Goktalay G, Levendusky M, Cavun S and Millington WR. Evidence that the lateral hypothalamus mediates the hemodynamic response to hemorrhage. Experimental Biology 2004, Washington D.C., April 2004.

Jean Taylor Taylor J. Designing the future of cytotechnology. New Frontiers in Gynecologic Cytopathology, Baystate Medical Center Annual Cytopathology Conference, Springfield, Mass., April 2004. Taylor J and Champagne D. The development of a vision-conceptualized, mission-driven standards-based curriculum for an educational system. American Society of Cytopathology, Chicago, Ill., November 2004. Taylor J. The cytotechnology profession and the Cytotechnology Advisory Committee (CAC): Embracing change and seizing opportunity. American Society of Cytopathology, Chicago, Ill., November 2004.

Taylor J. Licensure and the laboratory professions. American Society of Cytotechnology, Minneapolis, Minn., April 2005. Taylor J. Expanding cytotechnology into a new profession: Where do we go from here? American Society of Cytotechnology, Minneapolis, Minn., April 2005. HaiAn Zheng Sheng W, Zheng H and Xie XQ. 3D high-resolution NMR characterization of recombinant CB2 membrane protein fragment. 32nd Annual MALTO Medicinal Chemistry and Pharmacognosy Meeting, Oxford, Miss., May 2005. Zhao J, Zhang Y, Zheng H and Xie XQ. NMR structure of the human CB2 receptor fragment CB2(271-326). 10th Structural Biology Symposium, Galveston, Tex., May 2005. Zheng H. Structural biology in pharmaceutical sciences: A silent revolution. Zhejiang University College of Pharmacy, Hang Zhou, China and Fudan University School of Pharmacy, Shanghai, China, January 2005. Zheng H, Zhao J, Chen J, Xia Y and Xie XQ. NMR structure of a transmembrane helix bundle from G-protein coupled CB2 receptor. 18th Symposium of the Protein Society, San Diego, Calif., August 2004.

Scholarly activity | Humanities and Social Sciences

Publications Kenneth J. Blume Blume KJ. Instructor’s Guide with Test Item File, The Enduring Vision: A History of the American People, 5th Edition (Paul Boyer et. al., eds), Houghton Mifflin, Boston, 2005. Blume KJ. Albany College of Pharmacy, The Encyclopedia of New York State. Syracuse University Press, Syracuse, N.Y., 2005. Blume KJ. Hamilton College, The Encyclopedia of New York State. Syracuse University Press, Syracuse, N.Y., 2005. Leon E. Cosler Cosler LE, Eldar-Lissai A and Lyman GH. G-CSFs for management of febrile neutropenia. Hospital Pharmacy Europe: 65-66, September/October 2004. Cosler LE, Calhoun EA, Agboola O and Lyman GH. Effects of indirect and additional direct costs on the risk threshold for prophylaxis with colonystimulating factors in patients at risk for severe neutropenia from cancer chemotherapy. Pharmacotherapy 24(4):488-94, April 2004. Ross-Degnan D, Simoni-Wastila L, Brown JS, Gao X, Mah C, Cosler LE, Fanning T, Gallagher P, Salzman C, Shader RI, Inui TS and Soumerai SB. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. International Journal of Psychiatry in Medicine 34(2):103-23, 2004. Simoni-Wastila L, Ross-Degnan D, Mah C, Gao X, Brown J, Cosler LE, Fanning T, Gallagher P, Salzman C and Soumerai SB. A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. Clinical Therapeutics 26(2):322-36, February 2004. Clause SL, Triller DM, Bornhorst CP, Hamilton RA and Cosler LE. Conforming to HIPAA regulations and compilation of research data. American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists. 61(10):1025-31, May 2004.

Kevin Hickey Hickey K. Subject to colonialism: African self-fashioning and the colonial library. Review essay, Interventions: International Journal of Postcolonial Studies 6(1):135-136, 2004. Erika A. Muse Muse EA. The Evangelical Church In Boston’s Chinatown: A Discourse Of Language, Gender, And Identity. Routledge, New York, 2005. John M. Polimeni Polimeni JM, Holguin-Veras J, Cruz B, Xu N, List G, Haddock J and Nordstrom J. Off-peak freight deliveries: Challenges and stakeholders perceptions. Transportation Research Record, January 2005. Holguín-Veras J, Polimeni JM, Cruz B and List G. Off-peak freight deliveries to New York City: Challenges and policy measures. City Logistics IV (E. Taniguchi and R. Thomson, eds), Elsevier, Amsterdam, Netherlands: 547559, 2005. Polimeni JM, Holguin-Veras J, Cruz B, Xu N, List G, Haddock J and Nordstrom J. Off-peak freight deliveries: Challenges and stakeholders perceptions. Proceedings of the XIII Panamerican Conference of Traffic and Transportation Engineering, September 2004. Polimeni JM. Graduate education in ecological economics. Ecological Economics: The Journal of the International Society for Ecological Economics 51(3/4):287 – 293. Polimeni JM, Erickson JD, Gowdy JM, Limburg K, Nowosielski A and Stainbrook K. An integrated ecological economic assessment model for management of the Hudson River Watershed. Economics and Ecological Risk Assessment: Applications to Watershed Management (Randy Bruins and Matthew Heberling, eds), CRC Press, Boca Raton, Fla., 2004. Polimeni JM and Iorgulescu R. Energy efficency and Jevons Paradox. Proceedings of the Cairo 9th International Conference on Energy and Environment, Sharm El Sheikh, Egypt, March 2005. Laura Rogers Rogers L. When lifelines converge: Voices from the Forest Creative Writing Group. Reflections: A Journal of Writing, Service Learning and Community Literacy 4(1):12-23, Winter 2004.

Grants John M. Polimeni Project: Geographical Information Systems software (25 ArcView and Spatial Analyst LAB KIT PAKs, accessories and training sessions) Sponsor: Environmental Systems Research Institute, Inc., University Grant Current period: $106,780 Project period: $106,780

Abstracts/Presentations Margaret Carroll Carroll M. The fiction of Alice McDermott. New England Chapter of the American Conference for Irish Studies Annual Conference, Manchester, N.H., Fall 2004. Ray W. Chandrasekara Chandrasekara RW. Renting the lantern: Of wives and concubines. Crossroads 5th International Conference in Cultural Studies, University of Illinois, Urbana, Ill., June 2004. Chandrasekara RW. Modernism and the politics of madness in Yokomitsu Riichi’s Machine. Southeast Conference on Asian Studies, 44th Annual Meeting, Lexington, Ky., January 2005 Chandrasekara RW. Gods of small things. AsiaNetwork Conference, Whittier, Calif., April 2005. Timothy Coffey Coffey T and Rogers L. Tutoring writing at a science-oriented institution. Hudson Valley Community College Writers’ Conference, Troy, N.Y., May 2005.

Leon E. Cosler Cosler LE, Hornberger J and Lyman GH. Economic analysis of targeting chemotherapy using a 21 gene RT-PCR assay in lymph node negative, estrogen receptor positive early-stage breast cancer. Poster presentation, American Society of Clinical Oncology Annual Meeting, New Orleans, La., June 2004. Selby C, Cosler LE, Wolff D, Poniewierski M and Lyman GH. The epidemiology and treatment variation of ovarian cancer patients. Poster presentation, West Virginia University Undergraduate Research Symposium, Morgantown, W.Va., October 2004. Lodise TP, Gupta R, Cosler LE and Smith RP. Impact of empirical antibiotic selection on outcomes of patients with community-acquired pneumonia in the Upstate New York V.A. Healthcare Network. Poster presentation, 42nd Annual Meeting Infectious Diseases Society of America, Boston, Mass., October 2004. Eldar-Lissai A, Cosler LE and Lyman GH. Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy. Poster presentation, American Society of Hematology Annual Meeting, San Diego, Calif., December 2004. Lyman GH, Cosler LE and Hornberger J. A 21-gene RT-PCR assay in lymph node -, estrogen receptor +, earlystage breast cancer: An age-specific economic analysis. Poster presentation, San Antonio Breast Cancer Symposium, San Antonio, Tex., December 2004.

Bold – denotes ACP faculty collaborating on a project

Humanities and Social Sciences, cont’d.

Cosler L, Eldar-Lissai A, Dale D, Crawford J and Lyman GH. Economic analysis of prophylactic filgrastim and pegfilgrastim in cancer patients receiving chemotherapy. American Society of Clinical Oncology Annual Meeting, Orlando, Fla., May 2005. Angela Dominelli: Dominelli A. Personality traits of medical technologists: Implications for recruitment and retention. Business and Healthcare Administration Association Annual Meeting, Chicago, Ill., March 2005. Dominelli A. Track Chair, Multicultural perspectives in health care. Business and Health Care Administration Association Annual Meeting, Chicago, Ill., March 2005. Dominelli A. Discussant, Health Care Informatics, Research in Health Care, Compassionate Health Care and Health Care Marketing. Business and Health Care Administration Association Annual Meeting, Chicago, Ill., March 2005. Dominelli A. Service preference differences between community pharmacy and supermarket pharmacy patrons. International Business and Healthcare Administration Association Conference, Charleston, W. Va., October 2004. Dominelli A. Track Co-Chair, Quality in Health Care Track. International Business and Healthcare Administration Association, Charleston, W. Va., October 2004. J. Daniel d’Oney d’Oney JD. Educational segregation among Louisiana Indians. American Society for Ethnohistory Conference, Chicago, Ill., October 2004. d’Oney JD. A kingdom of water: Environmental change among the Houma Nation. American Society for Ethnohistory Conference, Chicago, Ill., October 2004. d’Oney JD. Moderator, Pedagogy in the academy. Southern Popular Culture Association Conference, New Orleans, La., September 2004.

d’Oney JD. Moderator, Native American topics. Southern Popular Culture Association Conference, New Orleans, La., September 2004. d’Oney JD. Native American portraiture: Beverly Dobbs, Gwendolen Cates and David P. Bradley. Southern Popular Culture Association Conference, New Orleans, La., September 2004. d’Oney JD. Brother bears and wild mustangs: Images of Native Americans in animation. Mid-Atlantic Popular/American Culture Association Conference, Buffalo, N.Y., November 2004. d’Oney JD. Chair, Northeast section, Current trends in Native American studies. Popular/American Culture Association Conference, San Antonio, Tex., April 2004. d’Oney JD. The persistence of Greek myth in modern American culture. Popular/American Culture Association Conference, San Antonio, Tex., April 2004. Kevin M. Hickey Hickey KM. Whose terra? Whose travail?: Postcolonial travel writing. Biennial Conference of the International Society for Travel Writing, Milwaukee, Wis., October 2004. Hickey KM. Cultivating Earth’s scars. New York College English Association Convention, Siena College, Loudonville, N.Y., April 2005. Hickey KM. Organizer and chair, Africana Spaces. New York College English Association Convention, Siena College, Loudonville, N.Y., April 2005. Andreas Karatsolis Karatsolis A. Multimedia materials for second language learning. 4th Biannual Clergy-laity Conference, New York, N.Y., July 2004. Karatsolis A. Technological affordances and academic source use. Computers and Writing Conference, Stanford University, Stanford, Calif., June 2005. Michael Pittman Pittman M. Organizer, G.I. Gurdjieff: Caucasian influence in contemporary thought and culture.Yerevan, Armenia, June 2005.

Pittman M. Gurdjieffian laughter: Demolition and reconstruction in Beelzebub’s tales to his grandson. 2nd Annual G.I. Gurdjieff Conference, Yerevan, Armenia, June 2005. John M. Polimeni Polimeni JM, Holguin-Veras J, Cruz B, Xu N, List G, Haddock J and Nordstrom J. Off-peak freight deliveries: Challenges and stakeholders perceptions. XIII Panamerican Conference of Traffic and Transportation Engineering, Albany, N.Y., September 2004. Polimeni JM, Holguin-Veras J, Cruz B, Xu N, List G, Haddock J and Nordstrom J. Off-peak freight deliveries: Challenges and stakeholders perceptions. Transportation Research Board of the National Academies 84th Annual Meeting, Washington D.C., January 2005. Polimeni JM. Graduate study in ecological economics. The Eighth Biennial Conference of the International Society for Ecological Economics, Montreal, Canada, July 2004. Polimeni JM and Batt HW. Synthesizing Georgist and ecological economics: Building from the classical tradition. The Eighth Biennial Conference of the International Society for Ecological Economics, Montreal, Canada, July 2004. Laura Rogers Rogers L. The secret souls of criminals: A different story about teaching in prison. Conference on College Composition and Communication, San Francisco, Calif., March 2005. Elisabeth Vines Vines E. Oil painting from “Window Treatment” series exhibited in Members’ Show. Fulton Street Gallery, Troy, N.Y., February 2005. Vines E. Envisioned, organized, and hung Members and Friends Art Show, including seven of her oil paintings. First Unitarian Society, Schenectady, N.Y.; June-September 2004.

Vines E. Two oil paintings from “Window Treatment” series (including catalog illustration) selected for 23rd Annual National Small Works Exhibit. Tri-County Arts Council, Cobleskill, N.Y., June 2005. Vines E. Three oil paintings from “GI Joe and Barbie” series exhibited in the Members’ Fences Show. Art Center of the Capital Region, Troy, N.Y., June 2005. Vines E. Oil from “GI Joe and Barbie” series selected for Fences Select Show. Art Center of the Capital Region, Troy, N.Y. July-August 2005.

Scholarly activity | Pharmacy Practice

Publications George R. Bailie Bailie GR. Calcium and phosphorus management in chronic kidney disease: challenges and trends. Formulary 39:358-362, 364-365, 2004. Bailie GR. The role of intravenous iron in anemia management. Pharmacy Practice News: 47-51, July 2004. Bailie GR. Therapeutic dilemmas in the management of peritonitis. Peritoneal Dialysis International 25:152-156, 2005. Bailie GR, Uhlig K and Levey AS. Clinical practice guidelines in nephrology: Evaluation, classification and stratification of chronic kidney disease. Pharmacotherapy 25:491-502, 2005.

Jennifer Cerulli Cerulli J, Zeolla MM and Cottrell JS. Drug information questions posed to community pharmacy advanced practice experience students. American Journal of Pharmaceutical Education 68(3):Article 68, 2004. Haggerty SA, Cerulli J, Zeolla MM, Cottrell JS, Weck MB and Faragon JJ. Community Pharmacy Target Intervention Program (TIP) to improve aspirin use in persons with diabetes. Journal of the American Pharmacists Association 45(1):17-22, 2005. Sara E. Dugan Dugan SE. Review of Pfizer Drug Symposium: Innovations in antipsychotic pharmacotherapy. College of Psychiatric and Neurologic Pharmacists Newsletter 8(1):6, June 2005.

Charytan C, Qunibi W, Bailie GR, et al. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron. Clinical Practice (online) 100:c55-c62, 2005.

Roland J. Elwell Elwell RJ.Thrombolytics for hemodialysis catheter clearance. Chronic Kidney Disease: Best Practice 2(1):1, 4, January/February 2005.

Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Peritoneal Dialysis International 25:107-131, 2005.

Elwell RJ and Foote EF. Hemodialysis and peritoneal dialysis. DiPiro JT et al, eds., Pharmacotherapy: A Pathophysiologic Approach, Sixth Edition, McGraw Hill: 851-870, 2005.

Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, et al. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients. American Journal of Kidney Diseases 45:119-126, January 2005.

Elwell RJ, Volino LR and Frye RF. Stability of cefepime in icodextrin peritoneal dialysis solution. The Annals of Pharmacotherapy 38:2041-44, 2004.

Bailie GR, Eisele G, Liu L, et al. Patterns of medication use in the RRI-CKD study: Focus on medications with cardiovascular effects. Nephrology Dialysis Transplantation 20:1110-1115, 2005. Bailie GR, Mason NA, Elwell RJ and Sy FZ. Analysis of medication use in peritoneal dialysis patients in two units. Peritoneal Dialysis International 25(3):287-90, 2005. Susan P. Bruce Briggs AL, Jackson T, Bruce SP and Shapiro N. The development and performance validation of a tool to assess patient anticoagulation knowledge. Research in Social and Administrative Pharmacy 1(1):40-59, 2005. Bruce SP and Burkiewicz JS. Guiding students through the residency selection process: A college based program. American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists 62:488-90, 2005.

Elwell RJ, Frye RF and Bailie GR. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis. Peritoneal Dialysis International 25(4):380-86, 2005. Darren W. Grabe Zillich AJ, Saseen JJ, DeHart RM, Dumo P, Grabe DW, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki MC and Joy MS. Caring for patients with chronic kidney disease: a joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy 25(1):123-43, January 2005. Joy MS, DeHart RM, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki M, Dumo P, Grabe DW, Saseen J and Zillich AJ. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: a joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. American Journal of Kidney Diseases 45(6):1105-1118, June 2005.

Thomas P. Lodise Lodise TP, Lomaestro BM, Danziger LH, Rodvold KA and Drusano GL. Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo Simulation. Antimicrobial Agents and Chemotherapy 48(12): 4718-4724, December 2004. Lodise TP and McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagnostic Microbiology and Infectious Diseases 52(2):113-22, June 2005. Lodise TP, Preston S, Bhargava V, Bryskier A, Nusrat R, Chapel S, Rangaraju M and Drusano GL. Pharmacodynamics of an 800 mg. dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens. Diagnostic Microbiology and Infectious Diseases, 52(1):45-52, May 2005. Yoo BK, Triller DM,Yong CS and Lodise TP. Gemifloxacin: A new fluoroquinolone approved for treatment of respiratory infections. The Annals of Pharmacotherapy 38(7-8):1226-35, July/August 2004. Teresa J. Lubowski Lewis JS, Boucher HW, Lubowski TJ, Ambegoankar AJ, Day DL and Patterson TF. Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis. Pharmacotherapy 25(6):839-846, 2005. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, Holst EM, Nichol MB, Shi SG, Livengood KB, Walden S and Lubowski TJ. Medication adherence and associated hemoglobin A1c in type 2 diabetes. The Annals of Pharmacotherapy 38(9):1357-62, September 2004. Margaret Malone Malone M. Enhancing pharmacist involvement in weight management: Time to get with the program. The Annals of Pharmacotherapy 38:1961-3, 2004. Malone M and Alger-Meyer SA. Medication use patterns after gastric bypass surgery for weight management. The Annals of Pharmacotherapy 39(4):637-42, April 2005. Malone M, Alger-Mayer SA, Anderson DA. Medication associated with weight gain may influence outcome in a weight management program. The Annals of Pharmacotherapy 39(7):1204-8, May 2005.

Malone M and Alger SA. Binge status and quality of life after gastric bypass surgery: A one year study. Obesity Research 12:473-481, 2004. Harold J. Manley Manley HJ and Cannella CL. Non-dialysis (home) medication utilization and cost in diabetic and non-diabetic hemodialysis patients. Nephrology News & Issues 19(2):27-8, 33-4, 36-8, 2005. Deal EN, Marken PA, Manley HJ and Garvin CG. Erythropoietin for prevention of anemia in the intensive care unit. Journal of Pharmacy Technology 20:283-286, 315-316, 2004. Manley HJ. Treating anemia in chronic kidney disease. Continuing Education Monograph, 1-12, September 2004. Manley HJ, Elwell RJ, Bailie GR and Welch C. Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125. The Annals of Pharmacotherapy 38(12):2035-2040, 2004. Sarah Scarpace Scarpace S, Hahn T, Roy H, Brown K, Paplham P, Chanan-Khan A, van Besien K and McCarthy PL Jr. Arterial thrombosis in four patients treated with thalidomide. Leukemia and Lymphoma 46(2):239-242, February 2005. Kara L. Shirley Ferraioli A, Shirley KL and David P. The role of atypical antipsychotics in glucose/insulin dysregulation and the evolving role of the psychiatrist in a new era of drug treatment options. CNS Spectrums, November 2004. Darren M.Triller Clause SL, Triller DM, Bornhorst CP, Hamilton RA and Cosler LE. Conforming to HIPAA regulations and compilation of research data. American Journal of Health-System Pharmacy 61(10):1025-1031, May 2004. Triller DM. Advancing patient safety in U.S. hospitals: Basic strategies for success. American Journal of Health-System Pharmacy 62(4):437-38, 2005. Nancy Waite Sarrafizadeh M, Waite NM, Hobson EH and Migden H. Patient cost savings through the use of pharmaceutical manufacturer assistance programs in a private ambulatory care setting. American Journal of Health-System Pharmacy 61:1816-20, 2004. Macary B. Weck Weck MB. Quoted in Prescription swapping: Sharing a budâ&#x20AC;&#x2122;s antibiotics can backfire. Cosmopolitan, October 2004. Bold â&#x20AC;&#x201C; denotes ACP faculty collaborating on a project

Pharmacy Practice, cont’d.

Weck MB. Putting out the fire of heartburn. Pharmacy Student, 37-38, May/June 2005. Mario Zeolla Zeolla MM and Cerulli J. Assessment of the effects of a community pharmacy women’s health education program on Management of Menopause Survey scores. Journal of Managed Care Pharmacy 10(5):442-48, 2004. Littlefield CL, Haines ST, Harralson AF, Schwartz AH, Scheafer SL, Zeolla MM and Flynn A. Academic pharmacy’s role in advancing practice and assuring quality in experiential education: Report of the 2003-2004 Professional Affairs Committee. American Journal of Pharmaceutical Education 68(3):S8, 2004.

Grants Jennifer Cerulli Project: Capital area pharmacists and pharmacy students provide community outreach Sponsor: FDA Office of Women’s Health “Innovative Projects” program Co-investigators: Margaret Malone, Diana D. Monaco Current period: $3,300 Project period: $3,300 Roland J. Elwell Project: Short-term medical mission to Nairobi, Kenya Sponsor: Christian Pharmacists Fellowship International Current period: $500 Project period: $500 Darren Grabe Project: The effect of intravenous iron on c-reactive protein in hemodialysis patients Sponsor: Albany College of Pharmacy Intramural Grant Co-investigator: Jan S. Simoni Current period: $5,000 Project period: $5,000 Thomas P. Lodise Project: Impact of delayed antibiotic treatment for Pseudomonas aeruginosa bacteremia Sponsor: Merck & Co, Inc. Co-investigators: Ben Lomaestro, Eileen Graffunder Current period: $13,750 Project period: $13,750 Project: Prediction model to identify patients with Pseudomonas aeruginosa infections at risk for piperacillintazobactam resistance. Sponsor: Albany College of Pharmacy Intramural Grant Co-investigators: Ben Lomaestro, Eileen Graffunder Current period: $5,000 Project period: $5,000

Project: Comparison of glucose intolerance between fluoroquinolones in elderly, hospitalized patients Sponsor: Albany College of Pharmacy Intramural Grant Co-investigators: Limor Schwarzbard (co- principal investigator), Ben Lomaestro, Raymond Smith Current period: $5,000 Project period: $5,000 Margaret Malone Project: Assessment of patient knowledge regarding nutritional supplements and identification of drug related problems following gastric bypass surgery Sponsor: Albany College of Pharmacy Intramural Grant Current period: $4,350 Project period: $4,350 Kara L. Shirley Project: Pharmacogenomic dissection of atypical antipsychotic induced endocrine disorders Sponsor: Albany College of Pharmacy Intramural Grant Co-investigators: Robert Keefe, Victoria Balkoski Current period: $5,000 Project period: $5,000 Darren M.Triller Project: Eddy VNA Medicaid Telehomecare Study Sponsor: New York State Department of Health Co-investigators: Michelle Mazzacco, Cheryl Articola Current period: $149, 687 Project period: $149, 687

Abstracts/Presentations George R. Bailie Bailie GR. Pharmacologic pitfalls in the management of peritonitis. Peritonitis Symposium, International Society of Peritoneal Dialysis Annual Meeting, Amsterdam, Netherlands, August 2004. Bailie GR. Interpreting the Kidney Disease Outcomes Quality Initiative clinical practice guidelines for management of bone disease in CKD. American Society of Managed Care Pharmacists Annual Meeting, Baltimore, Md., October 2004. Bailie GR. Management of anemia in CKD. American College of Clinical Pharmacy Annual Meeting, Nephrology Curricular Track, Dallas, Tex., October 2004. Bailie GR. Iron toxicity. Industry Speaks Symposium, Annual Dialysis Conference, Tampa, Fla., February 2005.

Bailie GR. Anemia and cardiovascular outcomes. Annual Louisiana Collaborative Meeting, New Orleans, La., March 2005. Bailie GR. Bone disease and anemia management in CKD. Omnicare, Detroit, Mich., March 2005. Bailie GR. CE for Renal Care Group Senior Administrators, Nashville, Ind., November 2004. Bailie GR. Parenteral iron in anemia of CKD. Northeast New York Society of Health-System Pharmacists, Albany, N.Y., December 2004. Bailie GR. Optimal use of parenteral iron. 39th Annual American Society of Health-System Pharmacists Midyear Symposium, Orlando, Fla., December 2004. Bailie GR. Parenteral iron: hypersensitivity and oxidative stress. Fifth Annual Renal Collaborative Meeting, New Orleans, La., February 2005. Bailie GR, Elder SJ, Asano Y, Cruz JM, Fukuhara S, Lopes AA, Mapes DL, Mason NA, Mendelssohn DC and Young EW. Sexual dysfunction in hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Poster presentation, American Society of Nephrology Annual Meeting, St. Louis, Mo., October 2004. Michael R. Brodeur Brandt NJ, Beizer JL, Brodeur MR and Davidson E. Timely topics in geriatrics: A review of current literature. American Society of Consultant Pharmacists Annual Meeting, San Francisco, Calif., November 2004. Susan P. Bruce Bruce SP and Stack NM. Poetry in motion: Influencing patient care through information mastery. Albany College of Pharmacy CE Program, November 2004. Bruce SP. Current medication issues in the management of chronic conditions. New York United Teachers, Latham, N.Y., May 2005. Bruce SP. Hypertension and dyslipidemia. NYS Foster Grandparents Program, Albany, N.Y., June 2005. Jennifer Cerulli Haggerty S, Cerulli J, Zeolla M, Cottrell J, Weck M and Faragon J. A community pharmacy Target Intervention Program (TIP) to initiate aspirin in persons with diabetes. Nonprescription Medicines Academy, Cincinnati Ohio, October 2004.

Sara E. Dugan Dugan SE. Aggression in adolescents: Use of atypical antipsychotics. New York State Coalition for Children’s Mental Health Services Annual Conference, Bolton Landing, N.Y., Nov. 2004. Dugan SE. Parkinson’s Disease: Evaluation of outcomes. Pharmacy Practice Institute, Albany, N.Y., April 2005. Dugan SE. Stimulants for ADHD: Friend or foe? Psychopharmacology Teaching Day, Albany, N.Y., April 2005. Roland J. Elwell Elwell RJ, Volino L and Frye RF. Stability of cefepime in icodextrin peritoneal dialysis solution. Pharmacotherapy 24:1447. Poster presentation, American College of Clinical Pharmacy Annual Meeting, Dallas, Tex., October 2004. Elwell RJ. Cinacalcet: A new treatment option for secondary hyperparathyroidism in dialysis patients. Northeast Tri-State Chapter of American Nephrology Nurses Association (ANNA), Peru, N.Y., November 2004. Elwell RJ. Cinacalcet: A new treatment option for secondary hyperparathyroidism in dialysis patients. Northeast Tri-State Chapter of American Nephrology Nurses Association (ANNA), Saratoga, N.Y., January 2005. Darren W. Grabe Grabe DW. Innovations in drug therapy for chronic kidney disease. American Nephrology Nurses Association 36th National Symposium, Las Vegas, Nev., April 2005. Bhakta NR, Grabe DW, Haqqie S and John L. Postdialysis rebound in a case of acute methanol poisoning. Poster presentation, 25th Annual Dialysis Conference, Tampa, Fla., February/March 2005. Grabe DW, Elwell RJ, Bailie GR and Brodeur MR. Prospective analysis of the impact of the Early Patient Oriented Care (EPOC) program on the ethical development of pharmacy students. American College of Clinical Pharmacy Spring Practice and Research Forum, Myrtle Beach, S.C., April 2005. Grabe DW, Cerulli J, Stroup J and Kane MP. Comparison of the Achilles Express® Ultrasonometer to dualenergy X-ray absorptiometry (DEXA). Poster presentation, American College of Clinical Pharmacy Spring Practice and Research Forum, Myrtle Beach, S.C., April 2005.

Grabe DW and Seifert CF. Characteristics of therapeutic monitoring of phenytoin in dialysis centers: A nationwide survey. Poster presentation, National Kidney Foundation Spring Clinical Meeting, Washington D.C., May 2005. Grabe DW. Innovations in drug therapy for chronic kidney disease. American Nephrology Nurses Association 36th National Symposium, Las Vegas, Nev., April 2005. Thomas P. Lodise Lodise TP. Epidemiology and outcomes of infections caused by methicillinresistant Staphylococcus aureus. MAKING A DIFFERENCE: 7th Annual International Conference of Infectious Diseases Pharmacotherapy, Litchfield Park, Ariz., May 2004. Lodise TP, Lomaestro BM, Rodvold KA, Danziger LH and Drusano GL. Pharmacodynamic (PD) profiling of piperacillin in hospitalized patients through the use of population pharmacokinetic modeling and Monte Carlo simulation. Poster presentation, 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C., October 2004. Lodise TP, Lomaestro BM and Drusano GL. Evaluation of the clinical and economic implications of an extended infusion dosing strategy of piperacillintazobactam for Pseudomonas aeruginosa infections. Poster presentation, 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C., October 2004. Lomaestro BM and Lodise TP. Comparison of glucose intolerance between gatifloxacin and piperacillin-tazobactam in elderly, hospitalized Patients. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C., October 2004. Deryke A, Lodise TP, Rybak MJ and McKinnon PS. Impact of empirical vancomycin treatment on outcomes for Staphylcoccus aureus pneumonia. Poster presentation, 42nd Annual Meeting Infectious Diseases Society of America, Boston, Mass., October 2004. Lodise TP, Gupta R, Cosler L and Smith RP. Impact of empirical antibiotic selection on outcomes of patients with community-acquired pneumonia in the Upstate New York V.A. Healthcare Network. Poster presentation, 42nd Annual Meeting Infectious Diseases Society of America, Boston, Mass., October 2004.

Rybak MJ, Lodise TP, Mckinnon PS, Williams EJ, Amjad M and Kaatz GW. Epidemiology of community-acquired methicillin-resistant Staphylococcus aureus with staphylococcal cassette chromosome mec type IV at an urban teaching hospital. Poster presentation, 42nd Annual Meeting Infectious Diseases Society of America, Boston, Mass., October 2004. Graves J, Lomaestro BM, Drusano GL and Lodise TP. Evaluation of the clinical and economic implications of an extended infusion dosing strategy of piperacillin-tazobactam for Pseudomonas aeruginosa infections. Poster presentation, 26th Annual Pharmacy Student Research ConferenceEastern States, Morgantown, W.Va., October 2004. Gupta R, Cosler L, Smith R and Lodise TP. Impact of empirical antibiotic selection on outcomes of patients with community-acquired pneumonia in the Upstate New York V.A. Healthcare Network. Poster presentation, 26th Annual Pharmacy Student Research Conference-Eastern States, Morgantown, W.Va., October 2004. Magera J, Lomaestro BM, Graffunder E and Lodise TP. Prediction model to identify patients with Pseudomonas aeruginosa infections at risk for piperacillin-tazobactam resistance. Platform presentation, 26th Annual Pharmacy Student Research Conference-Eastern States, Morgantown, W.Va., October 2004. Nashat M, Lomaestro BM, Graffunder E and Lodise TP. Impact of delayed antibiotic treatment for Pseudomonas aeruginosa bacteremia. Poster presentation, 26th Annual Pharmacy Student Research Conference-Eastern States, Morgantown, W.Va., October 2004. Patel N, Lomaestro BM and Lodise TP. Comparison of glucose intolerance between gatifloxacin and piperacillintazobactam in elderly, hospitalized patients. Platform presentation, 26th Annual Pharmacy Student Research Conference-Eastern States, Morgantown, W.Va., October 2004. Lodise TP. Why should antibiotic resistance be important to you, the consumer? New York State Department of Health and Save Antibiotic Strength New York: Antibiotic Resistance Impact on the Bottom Line, Albany, N.Y., October 2004. Lodise TP. Treatment of hospital-onset gram negative infections: Getting it right the first time. New York State Council of Health-system Pharmacists, Albany, N.Y., March 2005.

Lodise TP, Rhoney D, Tam V, Parker D and Drusano GL. Pharmacodynamic profiling of cefepime in the cerebrospinal fluid of hospitalized patients. Poster presentation, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark. April 2005. Lodise TP. Clinical implications and new treatment options for methicillinresistant Staphylococcus aureus. Western Massachusetts Society of HealthSystem Pharmacists, Springfield, Mass., April 2005. Lodise TP. Epidemiology and outcomes of infections caused by methicillinresistant Staphylococcus aureus. New York State Chapter of the American College of Clinical Pharmacy Spring Clinical Meeting, Rochester, N.Y., April 2005. Lodise TP. Antibiotic pharmacodynamics: Bug juice: How much do we need to squirt? 8th Congress on Infectious Diseases and Tropical Medicine, Symposia 25: Pharmacokinetics/ Pharmacodynamics. Hamburg, Germany, June 2005. Margaret Malone Malone M, Alger S and Anderson D. Incidence of medication associated with weight gain by participants in a weight loss program. Poster presentation, American College of Clinical Pharmacy Annual Meeting, Dallas, Tex., October 2004. Malone M, Alger S and Anderson D. The Lifestyle Challenge Program: a collaborative therapy management approach to obesity. Platform presentation, American College of Clinical Pharmacy Annual Meeting, Dallas, Tex., October 2004. Malone M. Altered drug disposition in obesity and post bariatric surgery, Obesity/Bariatric Medicine Clinical Symposium, Chicago, Ill., October 2004. Malone M. Altered drug disposition in obesity and after bariatric surgery. Critical Care Education Symposium, Capital District Region: Care of the Bariatric Patient, June 2005. Harold J. Manley Manley HJ. End of the line issues: Renal replacement therapies. American College of Pharmacy Annual Meeting, Nephrology Curricular Track, Dallas, Tex., October 2004. Manley HJ. Nephrology Review. American College of Clinical Pharmacy Spring Meeting, Pharmacotherapy Certification Preparatory Course, Myrtle Beach, N.C., April 2005.

Manley HJ. Medication therapy management in hemodialysis patients. DaVita Dialysis Inc., Chicago, Ill., April 2005. Manley HJ. Anemia management and parenteral iron. California Society of Health-System Pharmacists Annual Convention, Long Beach, Calif., November 2004. Manley HJ. Diabetes mellitus: Medical management. National Kidney Foundation Clinical Meeting, Washington, D.C., May 2005. Manley HJ. Nephrology. University of Missouri-Kansas City School of Pharmacy, Kansas City, Mo., May 2005. Manley HJ, Mason NA, St. Peter W and Bailie GR. Medication-related problems in ambulatory hemodialysis patients: Compilation of published reports. Poster presentation, American Society of Nephrology Annual Meeting, St. Louis, Mo., October 2004. Manley HJ and Cannella C. Non-Dialysis (home) medication utilization and cost in diabetic and non-diabetic hemodialysis patients. Poster presentation, American Society of Nephrology Annual Meeting, St. Louis, Mo., October 2004. Manley HJ, Drayer DK, Muther RS, Hebbar S and Miskulin D. Impact of multidisciplinary team on cardiovascular risk reduction in hemodialysis patients: Dialysis risk factor intervention trial. Poster presentation, American Society of Nephrology Annual Meeting, St. Louis, Mo., October 2004. Manley HJ and Drayer DK. Clinical pharmacy interventions reduce ambulatory hemodialysis patients cardiovascular risk. American Society of Nephrology Meeting, St. Louis, Mo., October 2004. Christopher Miller Miller C. Antiretroviral pharmacokinetics and toxicities. HIV Medicine Noon Conference: Albany Medical Center, Albany, N.Y., December 2004. Miller C. Antiretroviral therapy and adherence. Grand Rounds, St. Clareâ&#x20AC;&#x2122;s Hospital, Schenectady, N.Y., December 2004. Miller C. Pharmacokinetic concepts of antiretroviral agents. HIV Update, New York State Corrections Pharmacists, Albany, N.Y., March 2005. Miller C. Management of antiretroviral toxicities. Schenectady Family Practice, Schenectady, N.Y., March 2005. Bold â&#x20AC;&#x201C; denotes ACP faculty collaborating on a project

Pharmacy Practice, cont’d.

Miller C. Metabolic complications of antiretroviral therapy. St. Clare’s Hospital, Schenectady, N.Y., April 2005 Miller C. Antiretroviral therapy and medication errors. New York State Corrections Pharmacists teleconference, April 2005. Miller C. Antiretroviral therapy update: Inhibiting HIV-related mortality. Upper Hudson Primary Care Consortium, Plattsburgh, N.Y., May 2005. Miller C. Antiretroviral therapy and adherence: Steps toward survival. Pharmacy Practice Institute Conference, Albany, N.Y., April 2005. Miller C. Advances in antiretroviral pharmacokinetics and dosing: Optimizing the weapons against HIV. 6th Annual HIV Clinical Care Symposium, Albany, N.Y., June 2005. Miller C. Antiretroviral drug interactions: Case presentations. 6th Annual HIV Clinical Care Symposium, Albany, N.Y., June 2005. Miller C. Drug interactions with antiretrovirals: A case based approach. New York State Correctional Pharmacists, Albany Medical Center, Albany, N.Y., June 2005. Sarah L. Scarpace Scarpace SL. Pharmacotherapy for breast cancer. CE Program, Cytopathology Conference, Albany College of Pharmacy, Albany, N.Y., May 2005. Scarpace SL. Hormonal therapies for breast cancer. CE Program sponsored by Pfizer, Inc., Albany, N.Y., May 2005. Scarpace SL. Clinical use of anti-angiogenesis drugs. CE Program, Pharmacy Practice Institute, Albany, N.Y., April 2005. Scarpace SL. Herbal therapies and cancer patients. Gilda’s Club Open House, Latham, N.Y., April 2005. Lamonica DM, Bednarczyk EM, Scarpace SL, Vilani JW and Smith PF. The pharmacokinetics of IN-111 ibritumomab tiuexitan (ZevalinTM) radioimmuniotherapy in non-Hodgkin’s lymphoma. 52nd Annual Meeting of the Society of Nuclear Medicine, Toronto, Ontario, Canada, June 2005. Kara L. Shirley Shirley KL. An update on the pharmacotherapy of pediatric seizure disorders. CE Program, Pharmacy Practice Institute, Albany, N.Y., March 2004. Shirley KL. An update on the pharmacotherapy of aggression. 2004 Psychopharmacology Teaching Day, Albany, N.Y., April 2004.

Shirley KL. Pharmacotherapy of agitation, delirium and dementia. Thirteenth Annual Third Age Conference: Enhancing the qualities of life for senior persons with developmental disabilities, Saratoga Springs N.Y., May 2004. Shirley KL. An update on mood stabilizer pharmacotherapy for the treatment of bipolar disorders: Albany College of Pharmacy’s 2004 DUR Board Conference, Albany, N.Y., June 2004. Shirley KL. Pharmacotherapy of pediatric seizure disorders. 8th Annual Northeastern Psychiatric Pharmacotherapy Symposium, College of Psychiatric and Neurologic Pharmacists, Sturbridge, Mass., October 2004. Nicole M. Stack Stack NM and Melbourne KM. Impact of a diabetes collaborative care pilot program on patient outcomes, ACCP Annual Meeting, Dallas, Tex., October 2004. Stack NM. Update on hirsutism. New York State Electrolysis Association Conference, Albany, N.Y., November 2004. Stack NM. Smoking cessation: How can patients quit? Nursing Grand Rounds, St. Peter’s Hospital, Albany, N.Y., November 2004. Stack NM. A look at the pharmacologic treatments for smoking cessation. IPRO teleconference, December 2004. Stack NM. Smoking cessation: Treatment options and the approach to special populations. Capital District Tobacco Free Coalition Annual Meeting, December 2004. Stack NM. Pharmacist involvement in tobacco cessation education. New York State Council of Health-System Pharmacists Annual Assembly, Saratoga Springs, N.Y., April 2005. Stack NM. Managing your medications: Tools and tricks. Colonie Senior Services Center, Inc., Albany, N.Y., April 2005. Stack NM. Tobacco cessation: Guidelines and options. Northeast Health Network, Albany, N.Y., May 2005. Stack NM. Tobacco cessation training program. The Albany Citizens Council on Alcoholism and Other Chemical Dependencies, Inc., Albany, N.Y., June 2005.

Aimee F. Strang Strang AF, Zeolla M, Waite NM, Hamilton R, Briceland L and Andritz M. Use of an administrative evaluation tool to assess effectiveness of the Coordinating Council management model at Albany College of Pharmacy. American Association of Colleges of Pharmacy Annual Meeting, Salt Lake City, Utah, July 2004. Darren M. Triller Triller DM, Rugge J and Donnelly J. Travel-related savings through use of automated drug dispensing systems. American College of Clinical Pharmacy Spring Practice and Research Forum, Myrtle Beach, S.C., May 2005. Triller DM and Hamilton RA. In-home pharmaceutical care for patients with heart failure. American College of Clinical Pharmacy Spring Practice and Research Forum, Myrtle Beach, S.C., May 2005. Triller DM. Pharmacovigilance in a changing health care environment. Elder Law Course, Albany Law School, October 2004. Triller DM. Strategies in medication management. 3rd Annual Clinical Conference: Diabetes, Medication Management, and Telehealth Technology for Home Care, Home Care Association of New York, Albany, N.Y. October 2004. Triller DM. The importance of medication compliance. Long term care in the 21st century: 2004 Edgar & Margaret Sandman Fellowship Roundtable Discussion, Government Law Center, Albany Law School, Albany, N.Y., November 2004. Macary B. Weck Weck MB. Implementation: Incorporating patient care services into an existing community pharmacy practice. University of Florida Achieving Preceptor Excellence (APEX) CE Program, Orlando Fla., April 2005. Weck MB. Keeping up with innovative practice and guidelines. University of Florida Achieving Preceptor Excellence (APEX) CE Program, Orlando Fla., April 2005. Weck MB. The need for added caution: Special precautions for those with underlying health conditions, Take with Care Campaign media briefing, National Consumers League and the Food and Drug Administration, New York, N.Y., June 2004. Weck MB. Pharmacists as immunizers. Greater New York Hospital Association teleconference, September 2004.

Weck MB. If it’s over-the-counter, what do I need to know? Mangia/ Bountiful Bread/Butcher Block Making Strides Against Breast Cancer Health Series 2004, Albany N.Y., October 2004. Weck, MB. Emergency contraception pharmacy access programs. Unlimited Access: Unleashing the Potential of EC to Help End Unintended Pregnancies Panel Discussion, Family Planning Advocates Annual Conference, Albany, N.Y., January 2005. Parnapy SA and Weck MB. Development of a community pharmacybased breast health education program. American Pharmacists Association Annual Meeting, Orlando, Fla., April 2005. Mario M. Zeolla Zeolla MM. Managing dietary supplement drug interactions: What are the standards of practice? Albany College of Pharmacy CE program, Application of evidence-based standards to pharmaceutical care, Albany, N.Y., February 2005. Zeolla MM and Cottrell J. EckerdBrooks Diabetes Pharmacy Diabetes Training Program, East Greenbush, N.Y., March 2005. Zeolla MM. Warfarin interactions with dietary supplements: Where’s the evidence? 4th Annual Iowa Anticoagulation Symposium, University of Iowa Carver College of Medicine, Iowa City, Iowa, October 2004. Zeolla MM. Top 10 strategies for success as a clinician educator. Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, Fla., December 2004. Zeolla MM, Allie N and Brodeur MR, Dominelli A and Haines ST. Development and validation of an instrument to determine patient knowledge: The Oral Anticoagulation Knowledge (O.A.K.) Test. Poster presentation, 8th National Conference on Anticoagulant Therapy, Orlando, Fla., May 2005.

ACP Board of Trustees

OFFICERS Kandyce J. Daley ’74, Chair Zachary I. Hanan ’63, Vice Chair Michael F. Bette, Treasurer Robert F. McGaugh ’57, Secretary

TRUSTEES Murray R. Blair Jr. James E. Bollinger ’58 Robert S. Busch J. Gordon Dailey ’57 Christopher Del Vecchio ’88 Francis J. DiLascia ’54 Bridget-ann Hart ’80 Hugh A. Johnson David M. Kile ’74 Thomas O. Maggs Richard G. Robison ’52 Gary J. Salamido ’86 James Underwood John M. Woychick

CONSULTANTS Richard H. Daffner ’63 Joseph M. Lapetina

Research Contact Information

OFFICE OF GRANTS ADMINISTRATION M. Elyse Wheeler, Ph.D., MT (ASCP) Associate Dean of Graduate and Postgraduate Programs 518.694.7232 wheelere@acp.edu Robert M. Levin, Ph.D. Director of Research 518.694.7306 levinr@acp.edu Sunita Chowfin Project Coordinator 518.694.7144 chowfins@acp.edu

PHARMACEUTICAL RESEARCH INSTITUTE Shaker A. Mousa, Ph.D., M.B.A Executive Vice President and Chairman 518.694.7397 mousas@acp.edu

CHAIRMAN EMERITUS Alfred J. Collins Jr. ’53

TRUSTEE EMERITUS Kenneth M. Nirenberg

ACP Balance Sheet

ASSETS Cash and Cash Equivalents Investments Other Assets Accounts Receivable-Students Receivables-Government Entities Other Receivables Pledges Receivable Student Loans Receivable Agency Funds Deposits with bond Trustess Property,Plant & Equipment -Net Total Assets

June 30, 2005 $4,812,357 7,647,249 1,642,621 200,113 844,399 1,230,488 783,190 2,133,211 99,987 8,893,937 26,163,791 $54,451,343

LIABILITIES AND NET ASSETS Liabilities Accounts payable and accrued liabilities Deferred income and deposits U.S. government grants refundable Bonds Payable Capital lease obligation Expected Post Retirement Benefit Obligation Deposits held in custody for others Total Liabilities

$2,201,301 2,255,884 2,070,835 22,345,968 2,443,082 1,161,112 99,987 $32,578,169

Net Assets UNRESTRICTED: For current operations Funds functioning as an endowment Plant Fund Total unrestricted net assets

$1,250,044 3,971,841 11,012,826 $16,234,711

TEMPORARILY RESTRICTED: Unexpended funds received for restricted purposes College matching contribution to student loans Total temporarily restricted net assets PERMANENTLY RESTRICTED Endowment Funds Oâ&#x20AC;&#x2122;Brien Loan Fund Total permanently restricted net assets Total Net Assets Total Liabilities and Net Assets 28

$1,019,901 326,058 $1,345,959

$4,261,626 30,878 4,292,504 21,873,174 $54,451,343

REVENUES AND EXPENSES

June 30, 2005 Auxiliary Enterprises Student Tuition and Fees Other Sources Government Contracts and Grants Gifts and Pledges

Postgraduate Education

Investment Income Postgraduate Education

Revenues

Other Sources

73.63% 10.78% 1.22% 2.47%

Investment Income Gifts and Pledges

Auxiliary Enterprises

1.07% 3.83% 7.00%

Government Contracts and Grants

100.00%

Student Tuition and Fees Instruction/Student Services General Administration

17.54%

Postgraduate Education Research Student Financial Aid

8.79%

Institutional Advancement

Physical Plant

Expenses

1.81% 26.20%

Physical Plant Institutional Advancement

3.85%

Postgraduate Education Student Financial Aid

0.77%

Instruction/Student Services

Research

41.04% 100.00%

General Administration

Gifts and Donations Albany College of Pharmacy gratefully acknowledges the generous support received from alumni, corporations, foundations, faculty, staff, administration and friends. Whether it be a gift to the Annual Fund, sponsorship of a flag at the Dean’s Cup golf tournament, underwriting an event or program or a gift to a scholarship fund, this support contributes to furthering ACP’s dedication to the preparing and educating of students for the practice of pharmacy and related health care professions.

GIVING CLUBS Chairman’s Circle

Archibald McClure Circle

$25,000 and Over Anonymous The Coutu Foundation Kinney Drugs, Inc. Robison Foundation Albert M. White

$1,000 - $2,499 Accent Furniture, Inc. Allen’s Upholstery and Carpet Cleaning Nick G. Anagnost ’57 Babcock Financial Advisors, Inc. Allen Barnett Brian W. Bartle ’62 John W. Becker ’71 Frank C. Berning ’67 Bette & Cring, LLC James W. Bevilacqua ’79 James E. Bollinger ’58 Robert H. Brakemeier ’65 Brooks/Eckerd Pharmacy Brian ’96 & Stacey ’96 Bruyns Michael P. Buckley Kathleen B. Busch Robert S. Busch Shelly A. Calabrese Lucille Cerro Donald R. Charles Jr. ’67 Mona A. Cichello ’83 Robert ’76 & Glynis ’75 Clark William M. Cronin J. Gordon Dailey ’57 Thomas DellaRocca Kim ’75 & Rose Mary ’75 Demers Vicki A. DiLorenzo G. Winston Dobbins ’58 Daniel M. Durr Leonard E. Dwyer ’58 Eckerd Corporation Foundation Eli Lilly & Company Heather L. Ferrarese ’96 First Niagara Bank Frank C. Flannery ’66 Jane W. Fox ’68 Reeder ’68 & Sally ’68 Gates Frank ’76 & Mary ’78 Giamartino Rocco F. Giruzzi Jr. ’58 Paul J. Goldman Zachary I. Hanan ’63 David A. Hanson ’59 Lewis B. Helfstein ’68 William C. Irwin ’81 Hugh A. Johnson Jr. Michael ’84 & Teresa ’84 Kane Sally Ann Kay Krackeler Scientific, Inc. Robert J. Krackeler Joseph M. Lapetina Mary G. Lapetina Josie Leighton Michael B. Levine ’72 Marcia M. Locke ’73 Mabey’s Moving & Storage, Inc. Mia L. Mancuso Francesca A. Marchio Markel Corporation Frank Mauro ’71 Robert F. McGaugh ’57 Terry J. McGaugh ’96 Sergio A. Mendez Stephen B. Morgan ’70 James J. Morrissey Jr. ’65 NACDS Education Foundation George G. O’Connell Jr. ’57 Henry A. Palmer ’57 Barry ’69 & Linda ’70 Paraizo Carol R. Powell ’60

President’s Circle $15,000 - $24,999 Michael F. Bette Envision Architects PC James J. Gozzo Richard G. Robison ’52 TD Banknorth, N.A.

Dean’s Circle $10,000 - $14,999 Brooks/Eckerd Pharmacy CVS Richard H. Daffner ’63 Rinaldo V. DeNuzzo ’52 Melvin S. Friedland ’58 Jon J. Gallagher ’62 Pepsi

William Mansfield Circle $5,000 - $9,999 Abbott Laboratories Robert Brakemeier ’65 Charter One Bank F.S.B. Kandyce J. Daley ’74 Gateway Companies, Inc. James J. & Gloria Hunter Richard ’67 & Paula ’68 Jansen Gerald Katzman Kinney Drugs Foundation, Inc. Thomas O. Maggs Rolland C. Peckham ’41 * David Rubin & Carole Ju Walgreens

Willis Tucker Circle $2,500 - $4,999 Bristol-Myers Squibb Capital District Physicians Health Plan Anthony Chiffy Sr. ’60 Richard A. Cognetti ’69 ComDoc, Inc. John ’70 & Lynne ’69 Cote David P. Demagistris ’77 John J. Denio Rocco Femia Sr. ’60 First Albany Capital, Inc. Follett Corporation Geno ’83 & Theresa ’86 Germano GlaxoSmithKline, Inc. Anthony E. Laiacona Jr. ’76 Mark K. Maggy ’91 Michael L. Maggy ’85 Robert E. L. Nesbitt Charles W. Owens ’54 Pfizer, Inc. James J. Roome Jr. ’79 Rose & Kiernan, Inc. Howard A. Rubinger ’63 Lawrence K. Shanley Sr. ’66 Sodexho Inc. & Affiliates John Spanburgh ’64

Publix Super Markets Charities, Inc. William ’66 & Kathleen ’66 Quackenbush Ann-Maria T. Raco Dominic Raco Tina Raco Allen L. Rivlin ’62 Larry E. Small ’71 Bruce M. Spaulding ’67 Dexter B. Spaulding ’58 Harry S. Spaulding Jr. ’53 Troy D. Spaulding ’85 St. Peter’s Hospital Technical Building Services Alan P. Tubbs ’54 Gino Turchi Wal-Mart Stores, Inc. Wegmans Food Markets, Inc. Alison E. Willis ’94 Ron Winchell John M. Woychick Wyeth Laboratories Julie O. Yontz

Pharmacy Associate $500 - $999 Morris L. Abramson ’55 Arrow Leather Patricia C. Baron Joel Benware Earl R. Black ’91 Raymond J. Blake Jr. ’51 David ’83 & Anne ’87 Bombard Thomas L. Breon ’67 Ronald E. Bressinger ’78 James P. Byrnes ’66 Thomas E. Byrnes ’57 Francis A. Carbone ’63 Nicholas ’65 & Nancy ’65 Chervinsky ChevronTexaco Selig D. Corman ’58 Philip W. Cornell ’69 H. Russell Denegar ’43 Albert L. DiDonna ’65 Eugene E. DiNuzzo ’79 David D. Edwards ’65 Express Scripts/Value Rx John J. Faragon ’96 William Galarneau ’76 Thomas ’83 & Teresa ’83 Garcia Gregory ’71 & Barbara ’72 George Gail Goodman-Snitkoff Robert J. Gould Anthony J. Graziano ’84 Gale L. Gridley ’63 Vincent M. Grimaldi Sr. ’62 Zaven Hadidian ’60 Frederick S. Haggerty ’50 Wayne W. Halayko ’80 Rickey N. Hogle ’76 R. Gary ’72 & Olesia ’75 Hollenbeck Ellen L. Kennett ’91 David M. ’74 & Susan M. ’74 Kile John P. LeGrand ’70 Arthur J. Macarios ’57 Leo E. Maggy ’58 Richard M. Marasco ’57 Marilyn A. McCarthy ’54 Wayne ’65 & Christine ’65 McDonald Merrill Lynch Metro Resources, LLC Harry J. Mikhitarian ’54 Henry C. ’74 & Nancy ’74 Miller Jessica B. Morris

David J. Muller ’73 Martha Naber ’03 James W. Nowicki ’62 Barbara J. Olchek ’69 Wallace B. Pickworth ’69 John E. Romeo ’86 Victor G. Ross ’73 Thomas M. Sands ’66 Robert & Elizabeth Sawicki Regina G. Snyder ’47 Richard E. Sobiski ’65 David R. Stachnik ’77 Edgar V. Stevens ’67 Robert M. Stote ’60 Gregory ’80 & Elizabeth ’80 Szymaniak Larry G. Tabor ’88 Laura G. Tepper ’52 Scott M. Terrillion ’85 Tamara H. Turner ’88 Daniel J. Villa ’76 Frank A. Viviani ’58 Rose Audet Weglinski ’55 John T. Westerman Jr. ’78 M. Elyse Wheeler Walter ’51 & Eleanor ’54 Williams Patricia S. Wilson ’83 A. John Wylie ’68

Mortar & Pestle $250 - $499 Action Window Cleaning Co., Inc. Adirondack Cabling, Inc. All Seasons Services Andrew R. Allen ’68 Alumni Association of ACP, Inc. Ludwig A. Amann ’76 American Chemical & Equipment Co., Inc. Audio-Video Corporation Stephen ’87 & Jeannie ’97 Baratta Benefit Resource, Inc. Blue Shield of Northeastern New York Fred ’77 & Marylourdes ’77 Brundige Buffalo Hotel Supply Co., Inc. J. Michael ’77 & Joan M. ’78 Burns Jennifer Caloia Christine V. Camille ’86 Capital Area Pharmacists Society Andrew B. Carpenter David J. Carpenter ’81 Christopher K. Casey ’79 Joseph Chiffy ’94 Chubb & Son Carol A. Ciufo ’57 Elliot Cohen ’58 Colonie Mechanical Contractors, Inc. Russell D. Cranston ’69 Robert ’89 & Maryanne ’89 Davis Emanuel J. Diliberto Jr. ’67 Warren E. Doetsch ’58 Corey J. Duteau ’97 Lori Ehrensbeck George M. Ehrmann ’54 Excel Systems Inc. Christopher A. Fausel ’93 Philip ’87 & Barbara ’88 Favreau Warren D. Ficke ’59 Louis ’58 & Marilyn ’61 Fortin Julie-Ann Fortran ’89 Robert J. Fountaine ’97 C. David Fox ’58 Daniel Frodyma ’65 Sally Gangell Santo A. Garro ’60

L.Thomas ’92 & Maureen ’92 Geiser Mary Ann D. Godlewski ’72 Graphic Techniques, Inc. d/b/a W. L. Coughtry Co. Deborah A. Grimes ’77 John J. Guokas ’62 Mary E. Haggard ’83 Jessica A Halse James E. Harrington ’54 Robert C. Hartz Jr. ’66 Heslin Rothenberg Farley & Mesiti PC Hession Electric, Inc. Higher Education Marketing Associates, Inc Hiscock & Barclay, LLP Timothy M. Hiser Philip M. Hritcko ’83 Robert A. Huber ’61 Bernard G. Janeczko ’87 JCB Specialties, Inc. Joseph P. Mangione, Inc. Leon N. Kentner ’81 Paul ’71 & Ellen ’71 Koehler KONE, Inc. Albert J. Kronman ’53 David A. Kvancz ’79 Ronald E. Lesko Remo A. Lotano ’56 Mac-Gray Services, Inc. Main-Care Energy Karen L. Marsh ’89 Virginia M. McBride ’53 John F. McCarthy ’58 Patrick McGraw McKesson Corporation Ronald W. McLean ’51 Medicine Shoppe International, Inc. Anthony V. Merola ’94 Roxie J. Miles ’70 Milliman Consultants & Actuaries, Inc. MLB Industries, Inc. Edward P. Molloy ’62 Jack A. Monakey ’53 NEC Unified Solutions, Inc. Thomas H. Neely ’71 Patrick A. Nicol ’04 Patricia F. Osowick Mark ’91 & Karla ’82 Palmer Lauren Petraske Phelps Bros. Inc. Procter & Gamble Fund Jack A. Pross Sr. ’67 Provantage Funding Group Robinson Hall Architectural Products, Inc. Rochester Flooring Co. Ronald ’96 & Brandi ’96 Romano Richard A. Rubin ’61 Peter ’65 & Karen ’68 Ryan Pamela Sawchuk Brown Bernard E. Schallehn Robert C. Schmitt ’52 Gregory J. Sciarra ’93 Sentron Associates Nancy M. Shishik ’83 S. J. Dooling Building & Remodeling Robert G. Single ’69 Smith Barney Citigroup Kim L. Sprague ’78 Steven M St. Onge Stulmaker, Kohn & Richardson, LLP Tech Valley Communications TIAA-CREF Tracey J. Toner ’95 Kurt ’73 & Carol ’72 Trautmann

University Heights College Suites Ann M. Van de Wal David B. Van Etten ’61 Elwin E. Van Valkenburg ’52 Terri L. Wank ’89 Richard A. Weinstein ’77 Michael D. Willson ’83 Sheila Winnowski ’64 Peter ’88 & Karen ’88 Wirth Wayne F. Woodcock ’57 Paul R. Zalewski ’83 Jeffrey B. Zlotnick ’75

Maroon & White $100 - $249 Alicia A. Albertson ’00 Thomas W. Algozzine ’93 Rachelle A. Alig ’96 James L. Anderson Richard ’92 & Tracey ’92 Andrews Peter V. Arcidiacono ’57 Anne E. Astemborski ’85 Daniel M. Astry ’77 Alfred A. Austin Jr. ’97 Maria O. Bachynsky ’67 P. Edgar Badgley ’57 William A. Banovic ’68 Darrell S. Barber ’78 Kathleen C. Barclay ’74 G. Wesley Barnard ’58 James P. Bartholomew ’92 Raymond R. Bates ’63 Patrick ’80 & Deborah ’79 Bauman Richard D. Baylis ’61 Judith M. Beaulac ’72 Andrew P. Beelen ’90 Lena A. Beeson ’89 Bradd J. Beimford ’96 Edward A. Belemjian ’52 David J. Bendyk ’83 Henry R. Bennett ’31 Samuel F. Berardino III ’80 Charles J. Bernas ’57 Alan ’92 & Cory ’92 Bernstein Kathleen Bibbo ’80 Eileen Bidell ’85 Carlton A. Bigelow ’54 Dominick A. Bizzarro ’87 Stephen L. Blakeslee ’68 Jason M. Blitz ’02 Richard C. Blunden ’86 Nicholas S. Bonarrigo ’65 Kathleen E. Bonnier ’91 J. Mark Bover ’83 Ann Marie Z. Bowman ’70 Jane K. Boyd ’82 David C. Brands ’68 Laurie L. Briceland ’83 Orel E. Briceland Jr. ’49 Robert G. Brockley ’77 Nicholas R. Brogcinski ’03 Cynthia L. Brown ’84 Gerald J. Brown Scott W. Brown ’54 Susan P. Bruce ’98 Joseph R. Burgess ’72 Michael J. Calveric ’76 Valerie M. Campbell Frank Capristo Jr. ’70 Patricia B. Carney ’51 Alan J. Carpenter ’67 Brian M. Carroll ’79 Fred A. Carroll III ’82 Norman W. Carter ’68

Maria F. Carucci ’81 David R. Casler ’41 James D. Cataldi ’99 Central NY Society of Health Systems Jean B. Chambers ’46 Colleen A. Chestnut ’97 Albert G. Chmura ’69 Melissa E. Cloonan ’05 Esten Coan ’52 Michael E. Collins ’78 Gary ’66 & Norma Jean ’70 Coloton Ralph N. Comanzo ’58 Lois J. Conklin ’53 Susan K. Conklin ’94 Paul F. Consroe ’66 Samuel A. Coppola ’55 Jill M. Corbett ’89 Erin C. Corcoran David R. Corina ’52 Baird C. Couch ’62 John C. ’00 & Tracey ’01 Coultry Vincent A. Cozzarelli ’61 Keith F. Crimmins ’80 Laurie Cronin ’83 Everett D. Cronizer ’87 James ’87 & Colleen ’88 Cross Steven ’83 & Karen ’85 Crouch Thomas Curtis ’73 Jaclyn K. Dacier ’91 Laura R. Davis ’83 Geraldine A. DeGrazio ’68 Burton ’79 & Patti ’79 Deis Gilbert J. DeLucia ’53 Tammy M. Detore ’92 Danielle M. Diliberto Jennifer L. DiPasquale ’00 Kelly M. Doan ’94 Sean C. ’88 & Imelda ’88 Dobbins Angela C. Dominelli ’78 Patricia F. Donato ’79 Michael A. Duchnycz ’87 Tania M. Durante ’91 Real J. Duteau ’69 William J. Dwyer ’60 Mark T. Edgerly ’91 Charles C. Ehresman ’94 David ’83 & Mary ’83 Etz Rita A. Fahr ’79 Peter L. Fallon ’74 Christopher ’87 & Kathleen ’87 Fama Barbara Y. Farhoud ’95 Michael A. Farina ’88 Michael C. Federici ’73 Michael ’91 & Michele ’90 Fernandez Kevin J. Fessler ’99 Jocelyn R. Fiederer ’80 Laura Fifield ’04 Joseph Fiscella Jr. ’82 Melvin P. Fisher ’54 Robert Fizette ’83 William B. Fizette ’51 John D. Forman ’52 James Francese Jr. ’52 Dale ’82 & Maryann ’81 Franz Angelo M. Friello ’57 Thomas M. Friello ’80 William J. Furman ’71 Peter S. Gage ’81 Robert ’92 & Julie ’93 Galer Douglas M. Gay ’82 John R. George ’81 John F. Giacovelli ’72 David F. Giannuzzi ’68 Brendan L. Gilroy ’79 Joan D. Giombetti ’61

Paul J. Gionet ’78 Raymond P. Godlewski ’81 Stephen T. Godlewski ’65 Herbert T. Goggins Sr. ’59 Stanley R. Goldman ’51 Bernie B. Goldwin ’55 Allen Gordon Laurie A. Govel ’92 Bernard ’71 & Doreen ’72 Graham James T. Gratch ’79 Gene S. Gray ’69 Marilyn S. Green ’57 Martin J. Green Sean P. Greene ’00 James D. Grenier William ’85 & Dorothea ’83 Griffiths Frank ’74 & Marylee ’74 Grosso Joseph P. Guarino ’74 Gregory G. Guimond ’87 Theodore ’72 & Kathleen ’72 Hahn Kelly L. Haley Ann M. Hall ’70 Donald F. Hall ’59 Gary D. Hall ’57 Lyle B. Hall ’77 William ’58 & Ann ’58 Hallenbeck Gary W. Hamblen ’59 Steven ’85 & Joyce ’86 Hansel Marie R. Hare ’49 Sharon K. Harper ’92 Sema E. Hart ’83 William V. Hastings ’62 Herbert D. Heitmuller ’54 Frank A. Hempstead ’58 Jeffrey A. Hempstead ’84 Carl ’79 & Deborah ’77 Henderson Rebecca M. Hilborn ’95 Christopher T. Horning ’96 Walter ’48 & Betty ’45 Houghtaling Diana C. House ’86 Patrick ’71 & Patricia ’69 Howlett John ’70 & Paula ’73 Huebeler Murray P. Hyatt ’56 Judy J. Izard ’93 Leann K. Janeczko ’94 Johnson & Johnson Family of Companies Gary ’71 & Bessie ’72 Johnson Harold B. Jones ’51 Wallace C. Kahan ’52 Kyoung-Sil Kang ’97 Nyanza L. Kardelky ’95 Kevin C. & Elizabeth Kearns Christopher ’85 & Jennifer ’86 Klein Lester R. Kleinman ’59 Bertram L. Kohn ’60 Arthur ’59 & Jeannie ’59 Kramer Michael G. Kupiec ’91 Philip K. LaFluer Jr. ’94 John ’88 & Diane ’88 Lawatsch Susan N. Layne ’61 David ’77 & Kathleen ’77 Lee Francis D. Lee ’62 Edward Leighton Lawrence E. Lenihan ’69 Warren T. Lennox ’62 Edward A. Lenz ’56 Kimberly A. Leonard ’89 Pamela Leonardi Dale R. Lewis ’93 Douglas R. Lindke ’80 Paul G. Litynski ’77 Alfred A. Lotano ’61 Carmine Lotano ’58 James E. Ludlum ’52

Donald F. Lutz ’49 Frederick J. Macri ’74 John M. Mahanna ’61 Marc J. Mahay ’92 Ralph ’59 & Mary Lou ’60 Mancini Joseph ’93 & Heather ’97 Manley Richard A. Marra ’60 Bruce D. Martin ’55 Lisa Ann Mason ’83 Lester E. Maxik ’52 Edward J. Mc Nulty ’67 Jason R. McCann Paul T. McCann ’48 Richard K. McCann ’76 Michael H. McGinn ’89 Patrick S. McGraw Lynn K. McKinnon ’88 Becky L. McNulty ’89 Gordon H. Meagley ’51 Robert ’50 & Eleanor ’50 Messia Richard Miller ’50 Robert A. Miller ’54 Robert W. Miller ’59 Theodore L. Mitchell ’80 Lawrence H. Mokhiber ’71 Melvin Mones ’51 Margaret E. Morris ’94 Joseph G. Mount ’52 Philip P. Moyer ’70 Mary E. Murphy ’48 Anita N. Murray ’82 David M. Murray ’74 Scott W. Murray ’86 Thomas J. Natalie ’96 Charles A. Neely Jr. ’66 Krista B. Nelson ’94 Andrew E. Nielsen ’51 Harry P. Norman John S. North ’67 Gregory ’92 & Mary Lou ’91 Notaro David F. O’Connell ’67 Louis J. O’Connor ’66 John M. Ostrander ’68 Michael ’93 & Lori ’94 Panasci Andrew R. Perkins ’56 Ruth J. Perkins ’97 Wendy R. Perry ’78 Pamela R. Pesta ’84 Brenda L. Petrie ’00 Katherine F. Petrone ’59 Robert ’86 & Becky ’86 Petronio Henry J. Phillips ’57 Frederick G. Pickles ’52 Anne K. Pierson ’51 Samuel ’85 & Naomi ’85 Piraino Therese I. Poirier ’77 P. Ronald Pollack ’63 Eugene R. Ponessa ’53 Dominick ’75 & Ingeborg ’77 Porco Robert W. Potenza ’42 David G. Potter ’89 Kimberly C. Puglisi ’92 Darren M. Pynn ’88 Manuel Ramirez ’91 Arthur A. Ramsey ’62 Nancy J. Randall ’91 John Reepmeyer ’65 Mary Ellen Rinaldi ’83 Rite Aid Corporation Richard D. Robertello ’84 Barbara J. Rogler ’88 Warren C. Rolen ’62 Linda J. Ronk ’73 Linda E. Rosenthal ’77 Mathew M. Rosinski ’95

Daniel Rubinson ’52 Michael P. Ryan ’85 David A. Saelens ’69 John D. Salo ’91 Robert M. Santimaw ’61 Herbert V. Savage ’51 John H. Schell ’49 Matthew ’94 & Diane ’97 Scott James H. Serour ’72 John J. Sheeley Jr. ’63 Jay A. Sherline ’63 John F. Sherman ’49 Leonard G. Sherwood ’56 Michael S. Sherwood ’86 Scott ’89 & Carol ’89 Sherwood Christine A. Shields David Silverhart ’51 Luanne Sitterly ’94 James E. Skeals ’58 William ’66 & Alice ’66 Sliter Sodexho, Inc. Robert A. Sofia ’66 Erin E. Southwick ’94 Jason ’97 & Jennifer ’97 Southworth Kelley S. Spencer ’91 James R. Spillan ’56 Shirley C. Stolarski ’74 Aimee F. Strang ’95 Lewis W. Sturgess ’53 Michael J. Sube ’58 Robert S. Sullivan Jr. ’79 Gerald T. Sweet ’63 David E. Talarico ’62 Norton W. Taylor ’49 Philip Teicher ’51 Fred M. Thomas ’66 Jacqueline R. Thomas ’74 Kelly E. Toia ’87 Christopher A. Tomchik ’00 Edward ’81 & Rosemary ’81 Toomajian Robert M. Toomajian ’62 Darren ’89 & Anne ’89 Triller United Way of Tri-State Robert H. Van Vlack ’52 Pamela J. Walpole ’84 Helene M. Walsh ’60 Joseph M. Waltz ’91 William R. Warner ’54 Donna W. Warren ’77 Harold L. Weisberg ’55 Gretchen S. Welge ’78 Frederick L. Wendt ’67 Marcia R. Whitbeck ’88 David R. Wieland ’73 Ronald L. Wilcox ’62 Korey H. Willard ’80 Edward ’54 & Lois ’57 Wind Angela Wisniewski ’97 Leo A. Wisniewski ’72 Jean M. Witkowski ’93 Christine M. Wood ’78 Matthew T.Yancey ’99 Lois A. Yontz ’65 Richard J. Zalewski ’74 Michael J. Zandri ’84 Michael ’81 & Kimberly ’81 Zebrowski Karen M. Ziomek ’77 Jeffrey M. Zurek ’74

* Deceased

CLASS GIVING 1948

1931 Class Size: # of Donors: % of Participants: Henry R. Bennett

2 1 50

1941 Class Size: # of Donors: % of Participants: Total Gift: David R. Casler Rolland C. Peckham*

9 2 22 $5,131

1942 Class Size: # of Donors: % of Participants: Robert W. Potenza

12 1 8

Class Size: # of Donors: % of Participants: Total Gift: Armante J. Cerro* Walter Houghtaling Irmgard S. Kaiser Thomas C. Lopresti Paul T. McCann Mary E. Murphy

22 6 27 $2,940

1949 Class Size: # of Donors: % of Participants: Total Gift: Orel E. Briceland Jr. G. Robert Carney Betty B. Frink Marie R. Hare Donald F. Lutz John H. Schell John F. Sherman Norton W. Taylor

42 8 19 $950

1952

1955

1958

62 Class Size: # of Donors: 22 % of Participants: 35 $107,200 Total Gift: Edward A. Belemjian John A. Breault Donald H. Butlien Esten Coan David R. Corina Rinaldo V. DeNuzzo John D. Forman James Francese Jr. Wallace C. Kahan James E. Ludlum Lester E. Maxik Joseph G. Mount Frederick G. Pickles Richard G. Robison Daniel Rubinson Robert C. Schmitt Jerome B. Shapiro Laura G. Tepper Elwin E. Van Valkenburg Robert H. Van Vlack Gordon VanDeBogart

47 Class Size: # of Donors: 8 % of Participants: 17 $1,675 Total Gift: Morris L. Abramson Samuel A. Coppola James E. Gannon Bernie B. Goldwin Bruce D. Martin John D. Murphy Rose Audet Weglinski Harold L. Weisberg

69 Class Size: # of Donors: 26 % of Participants: 37 $20,335 Total Gift: Richard K. Barber G. Wesley Barnard James E. Bollinger Elliot Cohen Ralph N. Comanzo Selig D. Corman G. Winston Dobbins Warren E. Doetsch Leonard E. Dwyer Louis P. Fortin C. David Fox Melvin S. Friedland Rocco F. Giruzzi Jr. Barry Goldstein Ann S. Hallenbeck William C. Hallenbeck Frank A. Hempstead Bruce Kost Carmine Lotano Leo E. Maggy John F. McCarthy James E. Skeals Dexter B. Spaulding Michael J. Sube Harold E. Veeder Jr. Frank A. Viviani

1943 Class Size: # of Donors: % of Participants: H. Russell Denegar

14 1 7

1944 Class Size: # of Donors: % of Participants: Mary M. Andrews

6 1 16

7 1 14

1946 Class Size: # of Donors: % of Participants: Jean B. Chambers

12 1 8

1947 Class Size: # of Donors: % of Participants: Total Gift: Regina G. Snyder Frank J. Sweeney

Class Size: # of Donors: % of Participants: Total Gift: Frederick S. Haggerty Robert A. Messia Richard Miller Elizabeth V. Sheldon

56 4 7 $800

1951

1945 Class Size: # of Donors: % of Participants: Betty J. Houghtaling

1950

18 2 11 $525

Class Size: # of Donors: % of Participants: Total Gift: Kenneth E. Amsler Raymond J. Blake Jr. Patricia B. Carney Richard A. Eddy William B. Fizette Stanley R. Goldman Harold Jaffee Harold B. Jones David C. Lee Ronald W. McLean Gordon H. Meagley Melvin Mones Andrew E. Nielsen Anne K. Pierson Howard B. Rich Herbert V. Savage Martin Scully Harold W. Seitz Eugene D. Sherman David Silverhart Nancy W. Snyder Philip Teicher Alfred Weinstein Donald D. Weinstein Walter H. Williams

62 25 40 $3,280

1953 Class Size: 55 # of Donors: 9 % of Participants: 16 Total Gift: $2,275 Lois J. Conklin Gilbert J. DeLucia Albert J. Kronman John J. Kwasnowski Virginia M. McBride Jack A. Monakey Eugene R. Ponessa Harry S. Spaulding Jr. Lewis W. Sturgess

1954 Class Size: 59 18 # of Donors: % of Participants: 30 $8,045 Total Gift: Carlton A. Bigelow Scott W. Brown George M. Ehrmann Melvin P. Fisher David Gewirtzman Irving M. Gewirtzman Lorraine P. Godson James E. Harrington Herbert D. Heitmuller Marilyn A. McCarthy Harry J. Mikhitarian Robert A. Miller Charles W. Owens John J. Rivolta Jr. Alan P. Tubbs William R. Warner Eleanor S. Williams Edward W. Wind

1956 Class Size: # of Donors: % of Participants: Total Gift: Thomas F. Flynn Jr. Murray P. Hyatt William E. Kilburn III Edward A. Lenz Remo A. Lotano Andrew R. Perkins A. Alan Rand Leonard G. Sherwood James R. Spillan

55 9 16 $955

1957

1959

Class Size: 60 # of Donors: 24 % of Participants: 40 Total Gift: $9,015 Nick G. Anagnost Peter V. Arcidiacono P. Edgar Badgley Charles J. Bernas Jack E. Boylan Thomas E. Byrnes Carol A. Ciufo J. Gordon Dailey John L. Finnegan Angelo M. Friello Marilyn S. Green Gary D. Hall Sidney I. Keller Stephen B. Kistler Arthur J. Macarios Richard M. Marasco Robert F. McGaugh Elsie W. Mulrooney George G. O'Connell Jr. Henry A. Palmer Henry J. Phillips William J. Reilly Lois Wind Wayne F. Woodcock

Class Size: 67 # of Donors: 16 % of Participants: 23 Total Gift: $2,685 Warren D. Ficke Lawrence M. Gifford HerbertT. Goggins Sr. Donald F. Hall Gary W. Hamblen David A. Hanson Lester R. Kleinman Arthur Kramer Jeannie Kramer Ralph T. Mancini Robert W. Miller Raymond J. Mooney Katherine F. Petrone Burton W. Segelin Edward J. Trnka Betty L. Williams

1960 Class Size: # of Donors: % of Participants: Total Gift: Joseph M. Battaglia James H. Beatson Anthony Chiffy Sr. Claire D. Childs William J. Dwyer Rocco Femia Sr. Cynthia S. Gabriels Santo A. Garro Zaven Hadidian Edgar L. Jorolemon

62 19 30 $6,470

Bertram L. Kohn Mary Lou S. Mancini Richard A. Marra Carol R. Powell Carl E. Rosenfeld Jerald M. Stemerman Robert M. Stote Craig C. Stowell Helene M. Walsh

1961 Class Size: 75 # of Donors: 18 24 % of Participants: $2,405 Total Gift: Richard F. Arthur Richard D. Baylis Vincent A. Cozzarelli Celia F. Epstein Marilyn C. Fortin Sue C. McNamara Fox* Joan D. Giombetti Roy F. Hammecker Robert A. Huber A. Joseph Kallfelz Susan N. Layne Alfred A. Lotano John M. Mahanna Harry P. Norman Richard A. Rubin Robert M. Santimaw Thomas A. Somlo David B. Van Etten

1962 Class Size: 76 # of Donors: 19 % of Participants: 25 Total Gift: $6,120 Brian W. Bartle Baird C. Couch Floyd Firman Jr. Jon J. Gallagher Vincent M. Grimaldi Sr. William V. Hastings Craig P. Johnson Francis D. Lee Warren T. Lennox Edward P. Molloy Joan E. Murray James W. Nowicki Arthur A. Ramsey Allen L. Rivlin Warren C. Rolen David E. Talarico Robert M. Toomajian Ronald L. Wilcox Raymond Zywot

1963 Class Size: # of Donors: % of Participants: Total Gift: Elizabeth L. Austin Raymond R. Bates Francis A. Carbone

91 20 21 $18,024

Vicki S. Kelsey Jacqueline P. Merrick Charles A. Neely Jr. Louis J. O'Connor William T. Quackenbush III Kathleen M. Quackenbush Thomas M. Sands Lawrence K. Shanley Sr. Alice M. Sliter William L. Sliter Robert A. Sofia Fred M. Thomas Marie G. Windover

William A. Cetnar Richard H. Daffner Daniel J. DelNegro Barry F. Edelstein Maureen Foley Gale L. Gridley Zachary I. Hanan Geoffrey H. Kimber P. Ronald Pollack Howard A. Rubinger Sandra R. Sansone John J. Sheeley Jr. Jay A. Sherline Gerald T. Sweet Barbara Thurston James L. Wilcox Paul S. Zimmons

1967

1964 Class Size: # of Donors: % of Participants: Total Gift: John Spanburgh Sheila Winnowski

16 2 12 $3,250

1965 Class Size: 87 # of Donors: 23 % of Participants: 26 Total Gift: $8,705 Nicholas S. Bonarrigo Robert H. Brakemeier Nancy F. Chervinsky Nicholas Chervinsky Albert L. DiDonna Thomas S. Drahushuk Jean L. Duvall David D. Edwards Daniel Frodyma Stephen T. Godlewski J. William Johnson Jr. Sally J. Lembcke John W. Mauger Christina A. McDonald Wayne F. McDonald Mary E. O'Hanlon John Reepmeyer Judith A. Ruth Peter J. Ryan Richard E. Sobiski Lois A. Yontz

1966 Class Size: # of Donors: % of Participants: Total Gift: James P. Byrnes Mary L. Carney James E. Chaffee Gary R. Coloton Paul F. Consroe Frank C. Flannery Robert C. Hartz Jr.

71 20 26 $8,243

Class Size: 79 # of Donors: 19 % of Participants: 24 $10,410 Total Gift: Maria O. Bachynsky Frank C. Berning Thomas L. Breon David R. Brooks Alan J. Carpenter Donald R. Charles Jr. Diane F. DeGroff Emanuel J. Diliberto Jr. Joadele C. Dumper Richard L. Jansen Barry B. Liepshutz Edward J. McNulty John S. North David F. O'Connell Henry L. Pelletier Jack A. Pross Sr. Bruce M. Spaulding Edgar V. Stevens Frederick L. Wendt

1968 89 Class Size: # of Donors: 23 % of Participants: 25 $17,610 Total Gift: Andrew R. Allen William A. Banovic Stephen L. Blakeslee David C. Brands Norman W. Carter Robert E. Christiansen Richard F. Cimildoro Geraldine A. DeGrazio Susann L. Dugo Jane W. Fox Reeder D. Gates Sally S. Gates David F. Giannuzzi Lewis B. Helfstein Anita B. Israel Paula A. Jansen Duane E. Kozak Ronald L. Munzberg John M. Ostrander Karen M. Ryan James E. Stanton Jane V. Vaughn A. John Wylie

1969 Class Size: 90 19 # of Donors: 25 % of Participants: $12,428 Total Gift: Stuart A. Berney Veronica M. Burling Albert G. Chmura Richard A. Cognetti Philip W. Cornell Lynne K. Cote Russell D. Cranston Real J. Duteau Gene S. Gray Laurence S. Herman Patricia A. Howlett Lawrence E. Lenihan John P. Martin Barbara J. Olchek Barry A. Paraizo Wallace B. Pickworth Michael J. Pinsonneault David A. Saelens Robert G. Single

1970

Frank Mauro David W. McEntarfer Lawrence H. Mokhiber Thomas H. Neely Shery W. Richardson Larry E. Small

1972 81 Class Size: 15 # of Donors: % of Participants: 25 Total Gift: $3,975 Judith M. Beaulac Joseph R. Burgess Michele S. Danish Barbara H. George John F. Giacovelli Mary Ann D. Godlewski Doreen Z. Graham Kathleen M. Hahn Theodore J. Hahn R. Gary Hollenbeck Bessie P. Johnson Michael B. Levine James H. Serour Carol G. Trautmann Leo A. Wisniewski

Class Size: 78 # of Donors: 19 % of Participants: 24 Total Gift: $8,985 Harvey M. Arbit Ann Marie Z. Bowman Larry M. Burling Frank Capristo Jr. Norma Jean W. Coloton John R. Cote Richard M. Cotrupe Linda L. Drew Ronald A. Gailey Ann M. Hall John C. Huebeler John P. LeGrand Mark S. Lenes Roxie J. Miles Stephen B. Morgan Philip P. Moyer Linda S. Paraizo Mary D. Pearson Edward J. Ryan

Class Size: # of Donors: % of Participants: Total Gift: Wesley A. Carroll Thomas Curtis Michael C. Federici Kathleen M. Galletta Vincent A. Galletta Paula H. Huebeler Marcia M. Locke Barbara S. Mandulak David J. Muller Andrew F. Nelsen Linda J. Ronk Victor G. Ross Kurt E. Trautmann David R. Wieland

1971

1974

Class Size: 78 # of Donors: 20 % of Participants: 25 Total Gift: $6,865 William E. Baisley John W. Becker Angelo M. Emmi Bernard G. Ettinger William J. Furman Gregory P. George Bernard W. Graham Patrick E. Howlett Gary P. Johnson Anne M. Klupa Ellen D. Koehler Paul F. Koehler Alfred E. Liddiard August L. Magnanti Jr.

Class Size: # of Donors: % of Participants: Total Gift: Kathleen C. Barclay Kandyce J. Daley Eileen L. Faist Peter L. Fallon Wayne F. Geiser Frank L. Grosso Marylee F. Grosso Joseph P. Guarino Wladmyr B. Jurkiw David M. Kile Susan M. Kile Frederick J. Macri Henry C. Miller Nancy Miller

1973 71 14 19 $3,400

87 23 26 $8,335

David M. Murray David A. Reagan Valentine F. Rymanowski Cecelia A. Steffek Shirley C. Stolarski Jacqueline R. Thomas David E. Urban Richard J. Zalewski Jeffrey M. Zurek

1975 Class Size: 107 # of Donors: 19 17 % of Participants: $6,970 Total Gift: Michael E. Belemjian Steven H. Berkowitz Glynis P. Clark Kim M. Demers Rose Mary C. Demers Edward F. Dombroski Sr. Ethel D. Frost Marie L. Greener David A. Grella Olesia A. Hollenbeck Esther Ann Kerwin Sharon A. Leary Thomas L. McManus Dennis P. Pidgeon Judith L. Pidgeon Dominick J. Porco Diane B. Sacco Russell A. Yandon Jeffrey B. Zlotnick

1976 Class Size: 105 # of Donors: 18 % of Participants: 17 Total Gift: $9,006 Ludwig A. Amann Michael J. Calveric Robert F. Clark Mark E. Corwin Thomas Fiore William Galarneau Frank G. Giamartino Kenneth Hogan Rickey N. Hogle Ellen J. Howe David A. Keyser Eric T. Klippel Anthony E. Laiacona Jr. Richard K. McCann Sara F. Nelsen Marc A. Pelc Daniel J. Villa Joanne M. Wisnieski

1977 Class Size: # of Donors: % of Participants: Total Gift: Daniel M. Astry Robert G. Brockley Fred E. Brundige

112 29 25 $8,865

Marylourdes T. Brundige J. Michael Burns Erik A. Debruin David P. Demagistris Marlene G. Dickson Deborah A. Grimes Lyle B. Hall Deborah U. Henderson Kevin Hoehn David S. Lee William J. Libera Paul G. Litynski Joseph A. Maiello Debra S. Masel Kathleen Mazzaferro-Lee Cathy A. Pelc Therese I. Poirier Ingeborg S. Porco Linda E. Rosenthal Kevin J. Schaffer David R. Stachnik Kathleen A. Toucher Donna W. Warren Susan E. Waterman Richard A. Weinstein Karen M. Ziomek

1978 Class Size: 115 # of Donors: 15 % of Participants: 13 Total Gift: $4,313 Darrell S. Barber Ronald E. Bressinger David B. Castle Michael E. Collins Angela C. Dominelli Mary E. Giamartino Paul J. Gionet Sandra A. Judge Julie C. Nissen Wendy R. Perry Gerald M. Reginelli Kim L. Sprague Gretchen S. Welge John T. Westerman Jr. Christine M. Wood

1979 Class Size: # of Donors: % of Participants: Total Gift: Deborah R. Bauman James W. Bevilacqua Brian M. Carroll Christopher K. Casey Burton F. Deis Patti D. Deis John Desieno Eugene E. DiNuzzo Anthony N. Donatelli Patricia F. Donato John R. Dorvee Catherine M. Eleiott Rita A. Fahr Brendan L. Gilroy James T. Gratch Bruce D. Hatch

127 24 18 $7,984

David A. Kvancz Mary Jo List Kathleen A. McCasland Earl W. Pease Mark A. Riegelhaupt James J. Roome Jr. Robert S. Sullivan Jr. Elizabeth S. Voss

Joseph Fiscella Jr. Dale H. Franz Douglas M. Gay Peter M. Lamanna Janet B. Moore Anita N. Murray Mark S. Palmer Gale E. Soltys Evelyn M. Vavra John P. Vavra Richard J. Zeppieri

1980 Class Size: 113 # of Donors: 18 % of Participants: 15 $3,020 Total Gift: Patrick R. Bauman Samuel F. Berardino III Kathleen Bibbo Keith F. Crimmins Jocelyn R. Fiederer Martin J. Fox Elizabeth C. Frank Thomas M. Friello Geraldine K. Gates Gary L. Grella Wayne W. Halayko Mark P. Laurin Douglas R. Lindke Theodore L. Mitchell Elizabeth A. Szymaniak Gregory Szymaniak Larry V. Watson Korey H. Willard

1981 Class Size: 124 # of Donors: 21 % of Participants: 16 Total Gift: $3,045 David J. Carpenter Maria F. Carucci David M. Crimmins James W. Duffy Jill W. Edd David Every Maryann R. Franz Jeffrey Fudin Peter S. Gage John R. George Raymond P. Godlewski William C. Irwin Leon N. Kentner Janet S. Korwan Neal E. Pease Edward L. Toomajian Rosemary S. Toomajian John F. Walker Michele S. Walker Kimberly M. Zebrowski Michael Zebrowski

1982 Class Size: # of Donors: % of Participants: Total Gift: Jane K. Boyd Julie K. Burns Fred A. Carroll III

118 14 11 $1,100

1983 106 Class Size: 32 # of Donors: % of Participants: 30 Total Gift: $9,905 David J. Bendyk David S. Bombard J. Mark Bover Laurie L. Briceland Mona A. Cichello Laurie Cronin Steven C. Crouch Susan L. Cuculich Charles A. Danneker III Laura R. Davis David E. Etz Mary A. Etz Robert Fizette Teresa M. Garcia Thomas P. Garcia Geno J. Germano Jr. Dorothea A. Griffiths Mary E. Haggard Sema E. Hart Bruce L. Hotchkiss Philip M. Hritcko Sandra J. Kamuda Lisa Ann Mason Julius A. Pasquariello Jerry F. Powers Mary Ellen Rinaldi John R. Ripley Nancy M. Shishik David M. Tenero Michael D. Willson Patricia S. Wilson Paul R. Zalewski

1984 Class Size: 108 # of Donors: 21 % of Participants: 19 $3,365 Total Gift: Robin J. Alteri Kevin J. Bates Cynthia L. Brown Robert L. Correia Anthony J. Graziano Jeffrey A. Hempstead Michael P. Kane Teresa H. Kane Harold F. Lehman Jr. Robert A. Loudis Wendy M. Macuga Mary J. Morgan Donald Morse Jeffery W. Opal Pamela R. Pesta

James H. Purcell Richard D. Robertello Angelo J. Ruperto Pamela J. Walpole Daria F. Yuschak Michael J. Zandri

1985 Class Size: # of Donors: % of Participants: Total Gift: Anne E. Astemborski Eileen Bidell Michelle Ceresia Karen M. Crouch William O. Griffiths Wendy M. Gwozdz Steven B. Hansel Christopher J. Klein Pamela B. Krolczyk Mary Beth Lavin Shonna B. Loudis Teresa J. Lubowski Michael L. Maggy Karen R. Miller Cathy M. Osborne Lisa A. Palmer Naomi M. Piraino Samuel T. Piraino Michael P. Ryan Gary H. Seaward Troy D. Spaulding Scott M. Terrillion Cathy A. Tillman

120 23 19 $5,550

1986 Class Size: 126 # of Donors: 16 % of Participants: 12 $4,495 Total Gift: Richard C. Blunden Christine V. Camille Mariangela K. Capozzi Theresa B. Germano Joyce Hansel Diana C. House Jennifer Klein-Caloia Patricia A. McMahon Scott W. Murray Christopher G. Palmer Becky B. Petronio Robert C. Petronio Jr. John E. Romeo Michael S. Sherwood Anne M. Sowinski

1987 Class Size: # of Donors: % of Participants: Total Gift: Patricia C. Baron Dominick A. Bizzarro Anne L. Bombard Marc D. Boulais Everett D. Cronizer James F. Cross

130 18 13 $2,605

Michael A. Duchnycz Dorothy A. Eno Christopher A. Fama Kathleen Fama Lori E. Farquhar Philip K. Favreau Jr. Gregory G. Guimond Bernard G. Janeczko Barbara J. Joyce Frank H. Klippel Susan M. Klippel Kelly E. Toia

1990

1993

1996

2000

Class Size: 113 9 # of Donors: 7 % of Participants: $515 Total Gift: Andrew P. Beelen Michele M. Fernandez James T. Galgano Wendy W. Galgano Sharon C. Geerts Laurie L. Nicknair-Lipski Colleen M. O'Donnell-Nichols Robert J. Plitnick Michelle L. Strong

Class Size: 119 18 # of Donors: 15 % of Participants: $1,955 Total Gift: Thomas W. Algozzine Lora R. Becker Brenda Blick Jennifer Cerulli Christopher A. Fausel Julie M. Galer Judy J. Izard Chong Ki Kim Dale R. Lewis Robert Makofske Joseph D. Manley Michael A. Panasci Colleen D. Patterson Kim M. Reynolds Diane G. Schroeder Gregory J. Sciarra Laura A. Stevens Jean M. Witkowski

Class Size: 121 12 # of Donors: 9 % of Participants: $5,675 Total Gift: Rachelle A. Alig Bradd J. Beimford Brian A. Bruyns Stacy Bruyns John J. Faragon Heather L. Ferrarese Christopher T. Horning Sharifa N. Lockridge Terry J. McGaugh Thomas J. Natalie Brandi L. Romano Ronald V. Romano

Class Size: # of Donors: % of Participants: Total Gift: Alicia A. Albertson John C. Coultry Jennifer L. DiPasquale Sean P. Greene Brenda L. Petrie Karen L. Smith Robert J. Tobin Christopher A. Tomchik

1988 Class Size: # of Donors: % of Participants: Total Gift: Laura A. Ahanj Colleen A. Cross Imelda N. Dobbins Sean C. Dobbins Michael A. Farina Barbara N. Favreau Diane M. Lawatsch John O. Lawatsch Paul Mangione Jr. Lynn K. McKinnon Darren M. Pynn Concetta C. Rahn Barbara J. Rogler Larry G. Tabor Tamara H. Turner Marcia R. Whitbeck Karen P. Wirth Peter E. Wirth

122 18 14 $3,917

1989 Class Size: 147 # of Donors: 26 17 % of Participants: $3,070 Total Gift: Guy W. Amsden Lena A. Beeson Pamela M. Bowers Jill M. Corbett Maryanne Davis Robert J. Davis Sharon A. Farrell Shanna A. Fitzpatrick Julie-Ann Fortran Nancy H. Huntington Mary Beth Juron Kimberly A. Leonard Karen L. Marsh Michael H. McGinn Becky L. McNulty Jacquelyn A. Peters Mitchell David G. Potter Bridget O. Rowan Michael J. Sessa Jr. Stephanie A. Sessa Carol W. Sherwood Scott F. Sherwood Maureen E. Sontz Anne E. Triller Darren M. Triller Terri L. Wank

1991 141 Class Size: 23 # of Donors: 16 % of Participants: Total Gift: $5,830 Earl R. Black Kathleen E. Bonnier Jaclyn K. Dacier Adam T. Drahushuk Tania M. Durante Mark T. Edgerly Saury D. Elfeldt Michael R. Fernandez Christopher L. Jacobsen Ellen L. Kennett Jeffrey J. Kirkby Michael E. Kolman Michael G. Kupiec Mark K. Maggy Maureen A. Millen Mary Lou Notaro Karla M. Palmer Joseph T. Patterson Manuel Ramirez Nancy J. Randall John D. Salo Kelley S. Spencer Joseph M. Waltz

1992 Class Size: 139 # of Donors: 19 13 % of Participants: Total Gift: $2,185 Richard S. Andrews Tracey L. Andrews James P. Bartholomew Alan M. Bernstein Cory A. Bernstein Jeffrey P. Burbank Tammy M. Detore Robert P. Galer L. Thomas Geiser Maureen A. Geiser Laurie A. Govel Sharon K. Harper Erin P. Kolman Marc J. Mahay Gregory Notaro Paul B. Pagnotta Daniel M. Pruski Kimberly C. Puglisi Deborah W. Simard

1994 Class Size: # of Donors: % of Participants: Total Gift: Todd D. Bourn Deborah E. Burbank Joseph Chiffy Susan K. Conklin Bonny K. Decastro Victoria R. Dingman Kelly M. Doan Charles C. Ehresman Philip E. Fassinger Leann K. Janeczko Kristin M. Kim Philip K. LaFluer Jr. Jessica M. Len Anthony V. Merola Margaret E. Morris Krista B. Nelson Lori A. Panasci Matthew Scott Luanne Sitterly Erin E. Southwick Alison E. Willis

136 21 15 $3,225

1997 Class Size: # of Donors: % of Participants: Total Gift: Christie L. Andrews Alfred A. Austin Jr. Jeannie K. Baratta Colleen A. Chestnut Corey J. Duteau Robert J. Fountaine Theresa A. Hepfinger Kyoung-Sil Kang Heather A. King Lara Marie LaPointe Heather A. Manley Ruth J. Perkins Diane P. Scott Jason S. Southworth Jennifer Southworth Michael E. Tauss Angela Wisniewski

135 17 12 $2,490

110 4 3 $115

136 5 3 $250

2003

145 5 3 $570

Class Size: # of Donors: % of Participants: Total Gift: Asim M. Abu-Baker Nicholas R. Brogcinski Ning Liao Martha Naber

127 4 3 $670

2004

1999 Class Size: # of Donors: % of Participants: Total Gift: Andrea M. Brooke James D. Cataldi Rebecca A. Conrad Robert Dicenzo Kevin J. Fessler Melissa Giuliano Matthew T. Yancey

Class Size: # of Donors: % of Participants: Total Gift: Thomas Grandville Nadia A. Hellenga Michael S. Leake Geraldine M. Voss

Class Size: # of Donors: % of Participants: Total Gift: Ellen E. Blake Jason M. Blitz Heather L. Dessureault Jacqueline S. Oetinger Leila M. Tibi

1995 Class Size: 126 # of Donors: 12 % of Participants: 9 $1,025 Total Gift: Barbara Y. Farhoud Christopher J. Garner Rebecca M. Hilborn Nyanza L. Kardelky Ellen J. Kenney Mary T. Lapuma Emerson S. Metzler Mathew M. Rosinski Aimee F. Strang Tracey J.Toner C. Michael White Laura R. White

2001

2002

1998 Class Size: # of Donors: % of Participants: Total Gift: Amanda L. Allen Stephen M. Baratta Susan P. Bruce Margery M. Fellenzer Greg R. Stanley

106 8 7 $895

129 7 5 $585

Class Size: # of Donors: % of Participants: Total Gift: Nicole A. Bulmer Laura Fifield Patrick A. Nicol

130 3 2 $500

2005 Class Size: # of Donors: % of Participants: Melissa E. Cloonan

109 1 1

* Deceased

CORPORATE GIVING $380,168 Abbott Laboratories Accent Furniture, Inc. Action Window Cleaning Co., Inc. Adirondack Cabling, Inc. All Seasons Services Allen's Upholstery and Carpet Cleaning Alumni Association of ACP, Inc. American Chemical & Equipment Co., Inc. Anonymous Arrow Leather Audio Video Corporation Babcock Financial Advisors, Inc. Benefit Resource, Inc. Bette & Cring, LLC Blue Shield of Northeastern New York Bristol-Myers Squibb Brooks/Eckerd Pharmacy Buffalo Hotel Supply Co., Inc. Capital Area Pharmacists Society Capital District Physicians Health Plan Charter One Bank F.S.B. ChevronTexaco Chubb & Son Colonie Mechanical Contractors, Inc. ComDoc, Inc. The Coutu Foundation CVS Envision Architects, PC Excel Systems, Inc. Express Scripts/Value Rx First Albany Capital, Inc. First Niagara Bank Follett Corporation Gateway Companies, Inc. GlaxoSmithKline, Inc. Graphic Techniques, Inc. d/b/a W. L. Coughtry Co. Heslin Rothenberg Farley & Mesiti, PC Hession Electric, Inc. Higher Education Marketing Associates, Inc Hiscock & Barclay, LLP JCB Specialties, Inc. Johnson & Illington Advisors, LLC

MATCHING COMPANIES Joseph P. Mangione, Inc. Kinney Drugs Foundation, Inc. Kinney Drugs, Inc. KONE, Inc. Krackeler Scientific, Inc. Mabey's Moving & Storage, Inc. Mac-Gray Services, Inc. Main-Care Energy Markel Corporation McKesson Corporation Merrill Lynch Metro Resources, LLC Milliman Consultants & Actuaries, Inc. MLB Industries, Inc. NEC Unified Solutions, Inc. Pepsi Pfizer, Inc. Pharmacia & Upjohn Foundation Phelps Brothers Procter & Gamble Fund Provantage Funding Group Publix Super Markets Charities, Inc. Rite Aid Corporation Robinson Hall Architectural Products, Inc. Rochester Flooring Co. Rose & Kiernan, Inc. Sano-Rubin Construction Services Sentron Associates S. J. Dooling Building & Remodeling Smith Barney Citigroup Sodexho Inc. & Affiliates Stulmaker, Kohn & Richardson, LLP TD Banknorth, N.A. Tech Valley Communications Technical Building Services TIAA-CREF United Way of Tri-State University Heights College Suites Walgreens Wal-Mart Foundation Wegmans Food Market, Inc. Wyeth Laboratories

$58,429 Brooks/Eckerd Eckerd Corporation Foundation Eli Lilly and Company GE Foundation GlaxoSmithKline, Inc. Hoffman-Laroche, Inc. IBM Corporation Johnson & Johnson Family of Companies Kinney Drugs, Inc. McKesson Corporation Medicine Shoppe Pfizer, Inc. Procter & Gamble Fund Publix Super Markets Charities, Inc. Sanofi-Synthelabo, Inc. Wyeth Laboratories

GIFTS-IN-KIND Bristol-Myers Squibb Hoffmann-La Roche Inc. Merck Company Foundation St. Peter's Hospital Neil J. Cervera The Desmond Ronald McLean Lee Anna Obos Rite Aid Corporation Kay William Wheeler

BEQUESTS REALIZED Rita E. Leighton â&#x20AC;&#x2122;86

OFFICE OF INSTITUTIONAL ADVANCEMENT The Office of Institutional Advancement at Albany College of Pharmacy supports the mission and strategic plan of the College by cultivating vital relationships and providing timely, relevant communication with our diverse constituencies. These audiences include alumni, corporations, foundations, government and community leaders, the media and the campus community. Through these activities, we seek to engage all of our constituents in the continuous advancement of ACP as a national leader in scientific education. Vicki A. DiLorenzo Vice President of Institutional Advancement 518.694.7331 dilorenv@acp.edu

Lynne M. DellaRocca Systems Administrator 518.694.7253 dellarol@acp.edu

Ron Lesko Director of Communications 518.694.7394 leskor@acp.edu

Sergio A. Mendez Executive Director of College Relations 518.694.7251 mendezs@acp.edu

Deanna Enello-Butler Associate Director of Advancement Research 518.694.7305 ennellod@acp.edu

Christine A. Shields Assistant Director of Communications 518.694.7389 shieldsc@acp.edu

Shelly A. Calabrese Director of Annual Programs 518.694.7304 calabres@acp.edu The 2005 Report of Gifts includes donations of $100 and up received from January 1, 2005, to December 31, 2005. Gifts received after December 31, 2005, will be included in the 2006 Report of Gifts. The accuracy of this report is important to us. Please contact the Office of Institutional Advancement at (518) 694-7253 to report any inaccuracies or omissions so that our records can be corrected.

ALBANY COLLEGE OF PHARMACY 106 New Scotland Avenue Albany, NY 12208-3492 1-888-203-8010 www.acp.edu